{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:25:59Z","timestamp":1790821559629,"version":"4.1.0"},"reference-count":351,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10787-025-02012-5","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T06:11:34Z","timestamp":1762582294000},"page":"7269-7314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Multiple sclerosis pathophysiology: a comprehensive review of genetic, environmental, and immunological drivers"],"prefix":"10.1007","volume":"33","author":[{"given":"Dlzar D.","family":"Ghafoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dlshad O.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hastyar H.","family":"Najmuldeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sewara J.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paywast J.","family":"Jalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fryad S.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayez","family":"Alghofaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahashty A.","family":"Zangana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarwer J.","family":"Al-Bajalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,8]]},"reference":[{"key":"2012_CR1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36835","author":"NZ Abidin","year":"2023","unstructured":"Abidin NZ, Jaffar TNT, Tajudin LSA, Liza-Sharmini AT (2023) Wall-eyed bilateral internuclear ophthalmoplegia as an early presentation of multiple sclerosis. Cureus. https:\/\/doi.org\/10.7759\/cureus.36835","journal-title":"Cureus"},{"issue":"2","key":"2012_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.smim.2003.12.008","volume":"16","author":"L Adorini","year":"2004","unstructured":"Adorini L, Giarratana N, Penna G (2004) Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin Immunol 16(2):127\u2013134","journal-title":"Semin Immunol"},{"issue":"1","key":"2012_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12967-018-1450-6","volume":"16","author":"S Agostini","year":"2018","unstructured":"Agostini S, Mancuso R, Guerini FR, D\u2019Alfonso S, Agliardi C, Hernis A, Zanzottera M, Barizzone N, Leone MA, Caputo D, Rovaris M (2018) HLA alleles modulate EBV viral load in multiple sclerosis. J Trans Med 16(1):80","journal-title":"J Trans Med"},{"issue":"5","key":"2012_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/gene.2010.30","volume":"11","author":"A Alcina","year":"2010","unstructured":"Alcina A, Vandenbroeck K, Otaegui D, Saiz A, Gonzalez JR, Fernandez O et al (2010) The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun 11(5):439\u2013445","journal-title":"Genes Immun"},{"issue":"1","key":"2012_CR5","doi-asserted-by":"publisher","first-page":"e29819","DOI":"10.1371\/journal.pone.0029819","volume":"7","author":"A Alcina","year":"2012","unstructured":"Alcina A, de Abad-Grau MM, Fedetz M, Izquierdo G, Lucas M, Fern\u00e1ndez \u00d3 et al (2012) Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations. PLoS ONE 7(1):e29819","journal-title":"PLoS ONE"},{"key":"2012_CR6","doi-asserted-by":"publisher","unstructured":"Alexander AL, Eun Lee J, Lazar M, Field AS (2007). Diffusion tensor imaging of the brain. Neurotherapeutics 4(3):316\u2013329. https:\/\/doi.org\/10.1016\/j.nurt.2007.05.011","DOI":"10.1016\/j.nurt.2007.05.011"},{"issue":"4","key":"2012_CR7","doi-asserted-by":"publisher","first-page":"028944","DOI":"10.1101\/cshperspect.a028944","volume":"9","author":"L Alfredsson","year":"2019","unstructured":"Alfredsson L, Olsson T (2019) Lifestyle and environmental factors in multiple sclerosis. Cold Spring Harb Perspect Med 9(4):028944","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"24","key":"2012_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.msard.2018.05.013","volume":"1","author":"AA Alghwiri","year":"2018","unstructured":"Alghwiri AA, Khalil H, Al-Sharman A, El-Salem K (2018) Depression is a predictor for balance in people with multiple sclerosis. Mult Scler Relat Disord 1(24):28\u201331","journal-title":"Mult Scler Relat Disord"},{"key":"2012_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12035-019-01698-3","volume":"57","author":"Z Alirezaei","year":"2020","unstructured":"Alirezaei Z, Pourhanifeh MH, Borran S, Nejati M, Mirzaei H, Hamblin MR (2020) Neurofilament light chain as a biomarker, and correlation with magnetic resonance imaging in diagnosis of CNS-related disorders. Mol Neurobiol 57:469\u2013491","journal-title":"Mol Neurobiol"},{"key":"2012_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2022.577935","author":"F Aloisi","year":"2022","unstructured":"Aloisi F, Cross AH (2022) Mini-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis. J Neuroimmunol. https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577935","journal-title":"J Neuroimmunol"},{"key":"2012_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jneuroim.2018.10.004","volume":"329","author":"M Alrouji","year":"2019","unstructured":"Alrouji M, Manouchehrinia A, Gran B, Constantinescu CS (2019) Effects of cigarette smoke on immunity, neuroinflammation and multiple sclerosis. J Neuroimmunol 329:24\u201334","journal-title":"J Neuroimmunol"},{"issue":"9","key":"2012_CR12","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1177\/1352458512473362","volume":"19","author":"E Alvarez","year":"2013","unstructured":"Alvarez E, Piccio L, Mikesell RJ, Klawiter EC, Parks BJ, Naismith RT et al (2013) CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions. Mult Scler J 19(9):1204\u20131208","journal-title":"Mult Scler J"},{"issue":"97","key":"2012_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jaut.2018.09.005","volume":"1","author":"C Ammitzb\u00f8ll","year":"2019","unstructured":"Ammitzb\u00f8ll C, von Essen MR, B\u00f6rnsen L, Petersen ER, McWilliam O, Ratzer R et al (2019) GPR15 + T cells are Th17 like, increased in smokers and associated with multiple sclerosis. J Autoimmun 1(97):114\u2013121","journal-title":"J Autoimmun"},{"key":"2012_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073696","author":"B Angeloni","year":"2021","unstructured":"Angeloni B, Bigi R, Bellucci G, Mechelli R, Ballerini C, Romano C, MDPI AG et al (2021) A case of double standard: sex differences in multiple sclerosis risk factors. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22073696","journal-title":"Int J Mol Sci"},{"key":"2012_CR15","doi-asserted-by":"crossref","unstructured":"Aranow C. Vitamin D and the Immune System [Internet]. 2011. Available from: http:\/\/jim.bmj.com\/","DOI":"10.2310\/JIM.0b013e31821b8755"},{"issue":"1","key":"2012_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12974-019-1517-1","volume":"16","author":"BM Arneth","year":"2019","unstructured":"Arneth BM (2019) Impact of B cells to the pathophysiology of multiple sclerosis. J Neuroinflamm 16(1):128","journal-title":"J Neuroinflamm"},{"issue":"1","key":"2012_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jmri.28408","volume":"57","author":"TC Arnold","year":"2023","unstructured":"Arnold TC, Freeman CW, Litt B, Stein JM (2023) Low-field MRI: clinical promise and challenges. J Magn Reson Imaging 57(1):25\u201344","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"2012_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/neuroglia6010006","volume":"6","author":"AV Arredondo-Robles","year":"2025","unstructured":"Arredondo-Robles AV, Rodr\u00edguez-L\u00f3pez KP, \u00c1vila-Avil\u00e9s RD (2025) Clinical management in multiple sclerosis. Neuroglia 6(1):6","journal-title":"Neuroglia"},{"issue":"1","key":"2012_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1365-2249.2010.04121.x","volume":"160","author":"A Ascherio","year":"2010","unstructured":"Ascherio A, Munger KL (2010) 99th dahlem conference on infection, inflammation and chronic inflammatory disorders: epstein-barr virus and multiple sclerosis: epidemiological evidence. Clin Exp Immunol 160(1):120\u2013124","journal-title":"Clin Exp Immunol"},{"issue":"1\u20132","key":"2012_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5606\/dsufnjt.2019.006","volume":"4","author":"ES Aslan","year":"2020","unstructured":"Aslan ES (2020) Motor neuron diseases: amyotrophic lateral sclerosis and spinal muscular atrophy. Demiroglu Sci Univ Florence Nightingale Trans J 4(1\u20132):46\u201351","journal-title":"Demiroglu Sci Univ Florence Nightingale Trans J"},{"key":"2012_CR21","doi-asserted-by":"publisher","first-page":"104501","DOI":"10.1016\/j.nbd.2019.104501","volume":"130","author":"KC Atkinson","year":"2019","unstructured":"Atkinson KC, Lee JB, Hasselmann JP, Kim SH, Drew A, Soto J et al (2019) Diffusion tensor imaging identifies aspects of therapeutic estrogen receptor \u03b2 ligand-induced remyelination in a mouse model of multiple sclerosis. Neurobiol Dis 130:104501","journal-title":"Neurobiol Dis"},{"issue":"5","key":"2012_CR22","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s00415-010-5863-2","volume":"258","author":"M Axelsson","year":"2011","unstructured":"Axelsson M, Malmestr\u00f6m C, Nilsson S, Haghighi S, Rosengren L, Lycke J (2011) Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis. J Neurol 258(5):882\u2013888","journal-title":"J Neurol"},{"key":"2012_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00225","author":"CS Baaklini","year":"2019","unstructured":"Baaklini CS, Rawji KS, Duncan GJ, Ho MFS, Plemel JR (2019) Central nervous system remyelination: roles of glia and innate immune cells. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2019.00225","journal-title":"Front Mol Neurosci"},{"issue":"7","key":"2012_CR24","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/ng.396","volume":"41","author":"M Bahlo","year":"2009","unstructured":"Bahlo M, Booth DR, Broadley SA, Brown MA, Foote SJ, Griffiths LR et al (2009) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 41(7):824\u2013828","journal-title":"Nat Genet"},{"key":"2012_CR25","doi-asserted-by":"crossref","unstructured":"Bakshi R, Thompson AJ, Rocca MA, Pelletier D, Dousset V, Barkhof F, et al (2008). Review MRI in multiple sclerosis: current status and future prospects [Internet]. Available from: http:\/\/neurology.thelancet.com","DOI":"10.1016\/S1474-4422(08)70137-6"},{"key":"2012_CR26","doi-asserted-by":"publisher","unstructured":"Bakshi R, Ariyaratana S, Benedict RHB, Jacobs L (2025). Fluid-Attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. DOI: https:\/\/doi.org\/10.1001\/archneur.58.5.742","DOI":"10.1001\/archneur.58.5.742"},{"key":"2012_CR27","first-page":"16","volume":"2","author":"J Bao","year":"2022","unstructured":"Bao J, Tu H, Li Y, Sun J, Hu Z, Zhang F et al (2022) Diffusion tensor imaging revealed microstructural changes in normal-appearing white matter regions in relapsing-remitting multiple sclerosis. Front Neurosci 2:16","journal-title":"Front Neurosci"},{"issue":"7","key":"2012_CR28","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1093\/brain\/124.7.1396","volume":"124","author":"F Barkhof","year":"2001","unstructured":"Barkhof F, van Waesberghe JHT, Filippi M, Yousry T, Miller DH et al (2001) T1 hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment. Brain 124(7):1396\u20131402","journal-title":"Brain"},{"issue":"7994","key":"2012_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-023-06618-z","volume":"625","author":"W Barrie","year":"2024","unstructured":"Barrie W, Yang Y, Irving-Pease EK, Attfield KE, Scorrano G, Jensen LT et al (2024) Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations. Nature 625(7994):321\u2013328","journal-title":"Nature"},{"issue":"1","key":"2012_CR30","doi-asserted-by":"publisher","first-page":"6488","DOI":"10.1038\/s41598-020-63613-4","volume":"10","author":"I Baskara","year":"2020","unstructured":"Baskara I, Kerbrat S, Dagouassat M, Nguyen HQ, Guillot-Delost M, Surenaud M et al (2020) Cigarette smoking induces human CCR6+ Th17 lymphocytes senescence and VEGF-A secretion. Sci Rep 10(1):6488","journal-title":"Sci Rep"},{"issue":"11","key":"2012_CR31","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/ng.2770","volume":"45","author":"AH Beecham","year":"2013","unstructured":"Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C et al (2013) Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 45(11):1353\u20131362","journal-title":"Nat Genet"},{"issue":"7374","key":"2012_CR32","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature10554","volume":"479","author":"K Berer","year":"2011","unstructured":"Berer K, Mues M, Koutrolos M, AlRasbi Z, Boziki M, Johner C et al (2011) Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479(7374):538\u2013541","journal-title":"Nature"},{"issue":"40","key":"2012_CR33","doi-asserted-by":"publisher","first-page":"10719","DOI":"10.7272\/Q6N58JH2","volume":"114","author":"K Berer","year":"2017","unstructured":"Berer K, Gerdes LA, Cekanaviciute E, Jia X, Xiao L, Xia Z et al (2017) Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Natl Acad Sci 114(40):10719\u201310724. https:\/\/doi.org\/10.7272\/Q6N58JH2","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"2012_CR34","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.3390\/ijms23063383","volume":"23","author":"T Biernacki","year":"2022","unstructured":"Biernacki T, Kokas Z, Sandi D, F\u00fcvesi J, Fricska-Nagy Z, Farag\u00f3 P et al (2022) Emerging biomarkers of multiple sclerosis in the blood and the CSF: a focus on neurofilaments and therapeutic considerations. Int J Mol Sci 23(6):3383","journal-title":"Int J Mol Sci"},{"key":"2012_CR35","doi-asserted-by":"crossref","unstructured":"Bijl M, Horst G, Limburg PC, Kallenberg CGM (2001) Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytes","DOI":"10.1046\/j.1365-2362.2001.00842.x"},{"key":"2012_CR36","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3389\/fimmu.2015.00565","volume":"6","author":"K Blauth","year":"2015","unstructured":"Blauth K, Owens GP, Bennett JL (2015) The ins and outs of B cells in multiple sclerosis. Front Immunol 6:565","journal-title":"Front Immunol"},{"key":"2012_CR37","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","volume":"366","author":"G Bloomgren","year":"2012","unstructured":"Bloomgren G, Richman S, Hotermans C, Subramanyam M, Goelz S, Natarajan A et al (2012) Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med 366:1870\u20131880. https:\/\/doi.org\/10.1056\/NEJMoa1107829","journal-title":"N Engl J Med"},{"issue":"1","key":"2012_CR38","doi-asserted-by":"publisher","first-page":"13366","DOI":"10.1038\/s41598-022-17344-3","volume":"12","author":"M Bostan","year":"2022","unstructured":"Bostan M, Chua J, Sim YC, Tan B, Bujor I, Wong D et al (2022) Microvascular changes in the macular and parafoveal areas of multiple sclerosis patients without optic neuritis. Sci Rep 12(1):13366","journal-title":"Sci Rep"},{"issue":"2","key":"2012_CR39","first-page":"107","volume":"67","author":"M Bostan","year":"2023","unstructured":"Bostan M, P\u00eervulescu R, Tiu C, Bujor I, Popa-Cherecheanu A (2023) OCT and OCT-A biomarkers in multiple sclerosis-review. Rom J Ophthalmol 67(2):107","journal-title":"Rom J Ophthalmol"},{"key":"2012_CR40","doi-asserted-by":"crossref","unstructured":"Bretscher PA (1999). A two-step, two-signal model for the primary activation of precursor helper T cells [Internet]. Vol. 96. Available from: www.pnas.org.","DOI":"10.1073\/pnas.96.1.185"},{"key":"2012_CR41","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/s41433-017-0010-2","volume":"32","author":"J Britze","year":"2018","unstructured":"Britze J, Frederiksen JL (2018) Optical coherence tomography in multiple sclerosis. Eye 32:884\u2013888","journal-title":"Eye"},{"issue":"10","key":"2012_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/1414-431x20209881","volume":"53","author":"DCF Bruno","year":"2020","unstructured":"Bruno DCF, Donatti A, Martin M, Almeida VS, Geraldis JC, Oliveira FS et al (2020) Circulating nucleic acids in the plasma and serum as potential biomarkers in neurological disorders. Braz J Med Biol Res 53(10):1\u201315","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"2012_CR43","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1007\/s00415-022-11535-8","volume":"270","author":"A Cagol","year":"2023","unstructured":"Cagol A, Fuertes NC, Stoessel M, Barakovic M, Schaedelin S, D\u2019Souza M et al (2023) Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis. J Neurol 270(4):2139\u20132148","journal-title":"J Neurol"},{"key":"2012_CR44","doi-asserted-by":"crossref","unstructured":"Cantorna MT, Hayes CE, Deluca HF (1996). Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis (vitamin D\/vitamin D deficiency\/myelin basic protein\/autoimmunity) [Internet]. Vol. 93. Available from: https:\/\/www.pnas.org","DOI":"10.1073\/pnas.93.15.7861"},{"issue":"40","key":"2012_CR45","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.7272\/Q6N58JH2","volume":"114","author":"E Cekanaviciute","year":"2017","unstructured":"Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA et al (2017) Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci 114(40):10713\u201310718. https:\/\/doi.org\/10.7272\/Q6N58JH2","journal-title":"Proc Natl Acad Sci"},{"key":"2012_CR46","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.neuropharm.2015.10.010","volume":"110","author":"KA Chamberlain","year":"2016","unstructured":"Chamberlain KA, Nanescu SE, Psachoulia K, Huang JK (2016) Oligodendrocyte regeneration: its significance in myelin replacement and neuroprotection in multiple sclerosis. Neuropharmacology 110:633\u2013643","journal-title":"Neuropharmacology"},{"key":"2012_CR47","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0074-7742(07)79026-8","volume":"79","author":"DM Chari","year":"2007","unstructured":"Chari DM (2007) Remyelination In multiple sclerosis. Int Rev Neurobiol 79:589\u2013620","journal-title":"Int Rev Neurobiol"},{"key":"2012_CR48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0074-7742(07)79003-7","volume":"79","author":"T Chitnis","year":"2007","unstructured":"Chitnis T (2007) The role of CD4 T cells in the pathogenesis of multiple sclerosis. Int Rev Neurobiol 79:43\u201372","journal-title":"Int Rev Neurobiol"},{"issue":"5","key":"2012_CR49","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1056\/NEJMoa0907839","volume":"362","author":"JA Cohen","year":"2010","unstructured":"Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X et al (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 362(5):402\u2013415","journal-title":"N Engl J Med"},{"issue":"9856","key":"2012_CR50","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(12)61769-3","volume":"380","author":"JA Cohen","year":"2012","unstructured":"Cohen JA, Coles AJ, Arnold DL, Confavreux C, Fox EJ, Hartung HP et al (2012) Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet 380(9856):1819\u20131828","journal-title":"Lancet"},{"issue":"11","key":"2012_CR51","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S1474-4422(19)30238-8","volume":"18","author":"JA Cohen","year":"2019","unstructured":"Cohen JA, Comi G, Selmaj KW, Bar-Or A, Arnold DL, Steinman L et al (2019) Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial. Lancet Neurol 18(11):1021\u20131033","journal-title":"Lancet Neurol"},{"issue":"9856","key":"2012_CR52","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(12)61768-1","volume":"380","author":"AJ Coles","year":"2012","unstructured":"Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ et al (2012) Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Lancet 380(9856):1829\u20131839","journal-title":"Lancet"},{"issue":"12","key":"2012_CR53","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1093\/brain\/awp228","volume":"132","author":"M Comabella","year":"2009","unstructured":"Comabella M, L\u00fcnemann JD, R\u00edo J, S\u00e1nchez A, L\u00f3pez C, Juli\u00e0 E et al (2009) A type i interferon signature in monocytes is associated with poor response to interferon-\u03b2 in multiple sclerosis. Brain 132(12):3353\u20133365","journal-title":"Brain"},{"issue":"11","key":"2012_CR54","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S1474-4422(19)30239-X","volume":"18","author":"G Comi","year":"2019","unstructured":"Comi G, Kappos L, Selmaj KW, Bar-Or A, Arnold DL, Steinman L et al (2019) Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial. Lancet Neurol 18(11):1009\u20131020","journal-title":"Lancet Neurol"},{"key":"2012_CR55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ana.25927","volume":"89","author":"G Comi","year":"2021","unstructured":"Comi G, Bar-Or A, Lassmann H, Uccelli A, Hartung HP, Montalban X et al (2021) Role of B cells in multiple sclerosis and related disorders. Annal Neurol 89:13\u201323","journal-title":"Annal Neurol"},{"issue":"3","key":"2012_CR56","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1474-4422(13)70308-9","volume":"13","author":"C Confavreux","year":"2014","unstructured":"Confavreux C, O\u2019Connor P, Comi G, Freedman MS, Miller AE, Olsson TP et al (2014) Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol 13(3):247\u2013256","journal-title":"Lancet Neurol"},{"key":"2012_CR57","doi-asserted-by":"publisher","unstructured":"Constantinescu CS, Farooqi N, O\u2019brien K, Gran B (2011). Themed Issue: translational neuropharmacology-using appropriate animal models to guide clinical drug development experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS) linked articles. https:\/\/doi.org\/10.1111\/bph.2011.164.issue-4","DOI":"10.1111\/bph.2011.164.issue-4"},{"key":"2012_CR58","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.pmr.2013.06.006","volume":"24","author":"KF Cook","year":"2013","unstructured":"Cook KF, Bamer AM, Roddey TS, Kraft GH, Kim J, Amtmann D (2013) Multiple sclerosis and fatigue. understanding the patient\u2019s needs. Phys Med Rehabil Clin N Am 24:653\u2013661","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"2012_CR59","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/ane.12431","volume":"132","author":"J Correale","year":"2015","unstructured":"Correale J, Gait\u00e1n MI (2015) Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection. Acta Neurol Scand 132:46\u201355","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"2012_CR60","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/brain\/awp033","volume":"132","author":"J Correale","year":"2009","unstructured":"Correale J, Ysrraelit MC, Gaitn MI (2009) Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 132(5):1146\u20131160","journal-title":"Brain"},{"issue":"8","key":"2012_CR61","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.4049\/jimmunol.1000588","volume":"185","author":"J Correale","year":"2010","unstructured":"Correale J, Ysrraelit MC, Gait\u00e1n MI (2010) Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. J Immunol 185(8):4948\u20134958","journal-title":"J Immunol"},{"issue":"1","key":"2012_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/biomedicines7010014","volume":"7","author":"J Correale","year":"2019","unstructured":"Correale J, Marrodan M, Ysrraelit MC (2019) Mechanisms of neurodegeneration and axonal dysfunction in progressive multiple sclerosis. Biomedicines 7(1):14","journal-title":"Biomedicines"},{"issue":"3","key":"2012_CR63","doi-asserted-by":"publisher","first-page":"E308","DOI":"10.1212\/WNL.0000000000201465","volume":"100","author":"R Cortese","year":"2023","unstructured":"Cortese R, Carrasco FP, Tur C, Bianchi A, Brownlee W, De Angelis F et al (2023) Differentiating multiple sclerosis from AQP4-neuromyelitis optica spectrum disorder and MOG-antibody disease with imaging. Neurology 100(3):E308\u2013E323","journal-title":"Neurology"},{"key":"2012_CR64","unstructured":"Cunniffe NG 2021. Promoting and measuring remyelination and neuroprotection in clinical trials of people with multiple sclerosis."},{"key":"2012_CR65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00415-019-09421-x","volume":"268","author":"N Cunniffe","year":"2021","unstructured":"Cunniffe N, Coles A (2021) Promoting remyelination in multiple sclerosis. J Neurol 268:30\u201344","journal-title":"J Neurol"},{"key":"2012_CR66","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1749-6632.2009.05133.x","volume":"1183","author":"JM Damsker","year":"2010","unstructured":"Damsker JM, Hansen AM, Caspi RR (2010) Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci 1183:211\u2013221","journal-title":"Ann N Y Acad Sci"},{"key":"2012_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0892-8","author":"KM Danikowski","year":"2017","unstructured":"Danikowski KM, Jayaraman S, Prabhakar BS (2017) Regulatory T cells in multiple sclerosis and myasthenia gravis. J Neuroinflammation. https:\/\/doi.org\/10.1186\/s12974-017-0892-8","journal-title":"J Neuroinflammation"},{"key":"2012_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1362629","author":"AV De Keersmaecker","year":"2024","unstructured":"De Keersmaecker AV, Van Doninck E, Popescu V, Willem L, Cambron M, Laureys G et al (2024) A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1362629","journal-title":"Front Immunol"},{"issue":"8","key":"2012_CR69","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3390\/nu9080913","volume":"9","author":"J de Toro-Mart\u00edn","year":"2017","unstructured":"de Toro-Mart\u00edn J, Arsenault BJ, Despr\u00e9s JP, Vohl MC (2017) Precision nutrition: a review of personalized nutritional approaches for the prevention and management of metabolic syndrome. Nutrients 9(8):913","journal-title":"Nutrients"},{"key":"2012_CR70","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00415-023-12007-3","volume":"271","author":"SR Delgado","year":"2024","unstructured":"Delgado SR, Faissner S, Linker RA, Rammohan K (2024) Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment. J Neurol 271:1515\u20131535","journal-title":"J Neurol"},{"key":"2012_CR71","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15:545\u2013558","journal-title":"Nat Rev Immunol"},{"key":"2012_CR72","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fmicb.2011.00166","volume":"2","author":"M Derrien","year":"2011","unstructured":"Derrien M, Van Baarlen P, Hooiveld G, Norin E, M\u00fcller M, de Vos WM (2011) Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Front Microbiol 2:166","journal-title":"Front Microbiol"},{"key":"2012_CR73","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54808","author":"R Dhabalia","year":"2024","unstructured":"Dhabalia R, Kashikar SV, Parihar PS, Mishra GV (2024) Unveiling the intricacies: a comprehensive review of magnetic resonance imaging (MRI) assessment of T2-weighted hyperintensities in the neuroimaging landscape. Cureus. https:\/\/doi.org\/10.7759\/cureus.54808","journal-title":"Cureus"},{"issue":"3","key":"2012_CR74","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1007\/s00415-022-11468-2","volume":"270","author":"AS Dietmann","year":"2023","unstructured":"Dietmann AS, Kruse N, Stork L, Gloth M, Br\u00fcck W, Metz I (2023) Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological\u2013serological correlative study. J Neurol 270(3):1416\u20131429","journal-title":"J Neurol"},{"key":"2012_CR75","doi-asserted-by":"crossref","unstructured":"Dong X, Lutz W, Schroeder TM, Bachman LA, Westendorf JJ, Kumar R, et al 2005. Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter [Internet]. Vol. 1, PNAS November. Available from:","DOI":"10.1073\/pnas.0506516102"},{"issue":"15","key":"2012_CR76","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.3390\/cancers13153767","volume":"13","author":"L Dubreuil","year":"2021","unstructured":"Dubreuil L, Chevallier P, Retiere C, Gagne K (2021) Relevance of polymorphic KIR and HLA class I genes in NK-cell-based immunotherapies for adult leukemic patients. Cancers 13(15):3767","journal-title":"Cancers"},{"key":"2012_CR77","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.4103\/1673-5374.221146","volume":"12","author":"AO Dulamea","year":"2017","unstructured":"Dulamea AO (2017) The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies. Neural Regen Res 12:1939\u20131944","journal-title":"Neural Regen Res"},{"issue":"1","key":"2012_CR78","first-page":"7043578","volume":"2018","author":"AC Dupont","year":"2018","unstructured":"Dupont AC, Largeau B, Guilloteau D, Santiago Ribeiro MJ, Arlicot N (2018) The place of PET to assess new therapeutic effectiveness in neurodegenerative diseases. Contrast Media Mol Imaging 2018(1):7043578","journal-title":"Contrast Media Mol Imaging"},{"key":"2012_CR79","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1212\/01.wnl.0000275229.13012.32","volume":"68","author":"R Dutta","year":"2007","unstructured":"Dutta R, Trapp BD (2007) Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68:S22\u2013S31","journal-title":"Neurology"},{"key":"2012_CR80","doi-asserted-by":"publisher","first-page":"680480","DOI":"10.3389\/fimmu.2021.680480","volume":"12","author":"B Duygu","year":"2021","unstructured":"Duygu B, Olieslagers TI, Groeneweg M, Voorter CE, Wieten L (2021) HLA class I molecules as immune checkpoints for NK cell alloreactivity and anti-viral immunity in kidney transplantation. Front Immunol 12:680480","journal-title":"Front Immunol"},{"key":"2012_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21175957","volume":"21","author":"A Dziedzic","year":"2020","unstructured":"Dziedzic A, Saluk-Bijak J, Miller E, Bijak M (2020) Metformin as a potential agent in the treatment of multiple sclerosis. Int J Mol Sci 21:1\u201319","journal-title":"Int J Mol Sci"},{"key":"2012_CR82","doi-asserted-by":"crossref","unstructured":"Ebers GC. Environmental factors and multiple sclerosis [Internet]. Vol. 7. 2008. Available from: www.soda.is.com","DOI":"10.1016\/S1474-4422(08)70042-5"},{"issue":"2","key":"2012_CR83","doi-asserted-by":"publisher","first-page":"eaax5936","DOI":"10.1126\/sciadv.aax5936","volume":"6","author":"KS Evonuk","year":"2020","unstructured":"Evonuk KS, Doyle RE, Moseley CE, Thornell IM, Adler K, Bingaman AM et al (2020) Reduction of AMPA receptor activity on mature oligodendrocytes attenuates loss of myelinated axons in autoimmune neuroinflammation. Sci Adv 6(2):eaax5936","journal-title":"Sci Adv"},{"issue":"5","key":"2012_CR84","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/j.1399-0039.2006.00694.x","volume":"68","author":"M Fedetz","year":"2006","unstructured":"Fedetz M, Matesanz F, Caro-Maldonado A, Fernandez O, Tamayo JA, Guerrero M et al (2006) OAS1 gene haplotype confers susceptibility to multiple sclerosis. Tissue Antigens 68(5):446\u2013449","journal-title":"Tissue Antigens"},{"key":"2012_CR85","doi-asserted-by":"publisher","first-page":"642384","DOI":"10.3389\/fnins.2021.642384","volume":"15","author":"C Ferreira-Atuesta","year":"2021","unstructured":"Ferreira-Atuesta C, Reyes S, Giovanonni G, Gnanapavan S (2021) The evolution of neurofilament light chain in multiple sclerosis. Front Neurosci 15:642384","journal-title":"Front Neurosci"},{"key":"2012_CR86","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/EB.S389632","volume":"15","author":"AG Filippatou","year":"2023","unstructured":"Filippatou AG, Calabresi PA, Saidha S, Murphy OC (2023) Spotlight on trans-synaptic degeneration in the visual pathway in multiple sclerosis. Eye and Brain 15:153\u2013160","journal-title":"Eye and Brain"},{"key":"2012_CR87","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","volume":"15","author":"M Filippi","year":"2016","unstructured":"Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L et al (2016) MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 15:292\u2013303","journal-title":"Lancet Neurol"},{"issue":"10","key":"2012_CR88","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.1007\/s00415-022-11193-w","volume":"269","author":"M Filippi","year":"2022","unstructured":"Filippi M, Amato MP, Centonze D, Gallo P, Gasperini C, Inglese M et al (2022) Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion. J Neurol 269(10):5382\u20135394","journal-title":"J Neurol"},{"key":"2012_CR89","doi-asserted-by":"crossref","unstructured":"Filippi M, Rocca MA, De Stefano N, Enzinger C, Fisher E, Horsfield MA, et al 2011. Magnetic resonance techniques in multiple sclerosis the present and the future. Arch Neurol [Internet]. 68(12). Available from: http:\/\/archneur.jamanetwork.com\/","DOI":"10.1001\/archneurol.2011.914"},{"issue":"1","key":"2012_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","volume":"162","author":"JM Fletcher","year":"2010","unstructured":"Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KHG (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162(1):1\u201311","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"2012_CR91","doi-asserted-by":"publisher","first-page":"e1164","DOI":"10.1212\/NXI.0000000000001164","volume":"9","author":"S Floro","year":"2022","unstructured":"Floro S, Carandini T, Pietroboni AM, De Riz MA, Scarpini E, Galimberti D (2022) Role of Chitinase 3\u2013like 1 as a biomarker in multiple sclerosis: a systematic review and meta-analysis. Neurol Neuroimmunol Neuroinflamm 9(4):e1164","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"2012_CR92","first-page":"380","volume":"20","author":"H Ford","year":"2020","unstructured":"Ford H (2020) Clinical presentation and diagnosis of multiple sclerosis. clinical medicine. J R Coll Physicians Lond 20(4):380\u2013383","journal-title":"J R Coll Physicians Lond"},{"key":"2012_CR93","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ncl.2010.12.011","volume":"29","author":"RJ Fox","year":"2011","unstructured":"Fox RJ, Beall E, Bhattacharyya P, Chen JT, Sakaie K (2011) Advanced MRI in multiple sclerosis: current status and future challenges. Neurol Clin 29:357\u2013380","journal-title":"Neurol Clin"},{"issue":"12","key":"2012_CR94","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","volume":"367","author":"RJ Fox","year":"2012","unstructured":"Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M et al (2012) Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med 367(12):1087\u20131097","journal-title":"N Engl J Med"},{"key":"2012_CR95","doi-asserted-by":"publisher","first-page":"A4","DOI":"10.1136\/ard.2010.149096.10","volume":"70","author":"BS Franek","year":"2011","unstructured":"Franek BS, Kariuki SN, Arrington J, Mikolaitis RA, Jolly M, Utset TO et al (2011) IRF8 allele associated with susceptibility to multiple sclerosis is associated with serum interferon \u03b1 and serologic profile in systemic lupus erythematosus. Ann Rheum Dis 70:A4-5","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2012_CR96","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1093\/brain\/awac438","volume":"146","author":"H Gaitsch","year":"2023","unstructured":"Gaitsch H, Franklin RJ, Reich DS (2023) Cell-free DNA-based liquid biopsies in neurology. Brain 146(5):1758\u20131774","journal-title":"Brain"},{"key":"2012_CR97","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/neuonc\/noae049","volume":"26","author":"N Galldiks","year":"2024","unstructured":"Galldiks N, Kaufmann TJ, Vollmuth P, Lohmann P, Smits M, Veronesi MC et al (2024) Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: a report of the PET\/RANO group. Neuro-Oncol 26:1181\u20131194","journal-title":"Neuro-Oncol"},{"issue":"1","key":"2012_CR98","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13561-024-00478-7","volume":"14","author":"NA Gallehzan","year":"2024","unstructured":"Gallehzan NA, Khosravi M, Jamebozorgi K, Mir N, Jalilian H, Soleimanpour S et al (2024) Cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing\u2013remitting multiple sclerosis: a systematic review. Health Econ Rev 14(1):12","journal-title":"Health Econ Rev"},{"key":"2012_CR99","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fcell.2016.00059","volume":"4","author":"DA Galloway","year":"2016","unstructured":"Galloway DA, Moore CS (2016) MiRNAs as emerging regulators of oligodendrocyte development and differentiation. Front Cell Dev Biol 4:59","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"2012_CR100","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ana.23880","volume":"73","author":"R Gandhi","year":"2013","unstructured":"Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS et al (2013) Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol 73(6):729\u2013740","journal-title":"Ann Neurol"},{"issue":"9","key":"2012_CR101","doi-asserted-by":"publisher","first-page":"e107979","DOI":"10.1371\/journal.pone.0107979","volume":"9","author":"Z Gao","year":"2014","unstructured":"Gao Z, Nissen JC, Ji K, Tsirka SE (2014) The experimental autoimmune encephalomyelitis disease course is modulated by nicotine and other cigarette smoke components. PLoS ONE 9(9):e107979","journal-title":"PLoS ONE"},{"key":"2012_CR102","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cca.2021.01.020","volume":"516","author":"Y Gao","year":"2021","unstructured":"Gao Y, Han D, Feng J (2021) Microrna in multiple sclerosis. Clin Chim Acta 516:92\u201399","journal-title":"Clin Chim Acta"},{"key":"2012_CR103","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.msard.2018.09.008","volume":"26","author":"M Gasim","year":"2018","unstructured":"Gasim M, Bernstein CN, Graff LA, Patten SB, El-Gabalawy R, Sareen J et al (2018) Adverse psychiatric effects of disease-modifying therapies in multiple sclerosis: a systematic review. Mult Scler Relat Disord 26:124\u2013156","journal-title":"Mult Scler Relat Disord"},{"key":"2012_CR104","first-page":"12","volume":"16","author":"Z Gharaylou","year":"2021","unstructured":"Gharaylou Z, Sahraian MA, Hadjighassem M, Kohanpour M, Doosti R, Nahardani S et al (2021) Widespread disruptions of white matter in familial multiple sclerosis: DTI and NODDI study. Front Neurol 16:12","journal-title":"Front Neurol"},{"key":"2012_CR105","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/imm.13198","volume":"160","author":"T Gharibi","year":"2020","unstructured":"Gharibi T, Babaloo Z, Hosseini A, Marofi F, Ebrahimi-kalan A, Jahandideh S et al (2020) The role of B cells in the immunopathogenesis of multiple sclerosis. Immunology 160:325\u2013335","journal-title":"Immunology"},{"key":"2012_CR106","doi-asserted-by":"publisher","first-page":"950465","DOI":"10.3389\/fimmu.2023.950465","volume":"14","author":"A Ghaseminejad-Raeini","year":"2023","unstructured":"Ghaseminejad-Raeini A, Ghaderi A, Sharafi A, Nematollahi-Sani B, Moossavi M, Derakhshani A et al (2023) Immunomodulatory actions of vitamin D in various immune-related disorders: a comprehensive review. Front Immunol 14:950465","journal-title":"Front Immunol"},{"issue":"1","key":"2012_CR107","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12883-024-03550-1","volume":"24","author":"M Ghazanfari Hashemi","year":"2024","unstructured":"Ghazanfari Hashemi M, Talebi V, Abbasi Kasbi N, Abbasi M, Asgari N, Sahraian MA (2024) T1 hypointense brain lesions in NMOSD and its relevance with disability: a single institution cross-sectional study. BMC Neurol 24(1):62","journal-title":"BMC Neurol"},{"key":"2012_CR108","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00011-018-1185-0","volume":"68","author":"M Gholamzad","year":"2019","unstructured":"Gholamzad M, Ebtekar M, Ardestani MS, Azimi M, Mahmodi Z, Mousavi MJ et al (2019) A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future. Inflamm Res 68:25\u201338","journal-title":"Inflamm Res"},{"key":"2012_CR109","doi-asserted-by":"crossref","unstructured":"Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, Van Den Bos GAM 2001. Causes and consequences of comorbidity: a review [Internet]. J Clin Epidemiol. Vol. 54, Available from: www.rivm.nl\/public","DOI":"10.1016\/S0895-4356(00)00363-2"},{"issue":"9","key":"2012_CR110","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3109\/09638288.2016.1170212","volume":"39","author":"AM Giovannetti","year":"2017","unstructured":"Giovannetti AM, Brambilla L, Torri Clerici V, Antozzi C, Mantegazza R, \u010cerniauskait\u0117 M et al (2017) Difficulties in adjustment to multiple sclerosis: vulnerability and unpredictability of illness in the foreground. Disabil Rehabil 39(9):897\u2013903","journal-title":"Disabil Rehabil"},{"issue":"5","key":"2012_CR111","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1056\/NEJMoa0902533","volume":"362","author":"G Giovannoni","year":"2010","unstructured":"Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, S\u00f8rensen PS et al (2010) A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N Engl J Med 362(5):416\u2013426","journal-title":"N Engl J Med"},{"issue":"1","key":"2012_CR112","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1038\/s41467-019-13527-1","volume":"10","author":"O Glaich","year":"2019","unstructured":"Glaich O, Parikh S, Bell RE, Mekahel K, Donyo M, Leader Y et al (2019) DNA methylation directs microRNA biogenesis in mammalian cells. Nat Commun 10(1):5657","journal-title":"Nat Commun"},{"issue":"12","key":"2012_CR113","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","volume":"367","author":"R Gold","year":"2012","unstructured":"Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K et al (2012) Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 367(12):1098\u20131107","journal-title":"N Engl J Med"},{"issue":"1","key":"2012_CR114","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41514-024-00176-y","volume":"10","author":"PT Gomez","year":"2024","unstructured":"Gomez PT, Carver CM, Rodriguez SL, Wang L, Zhang X, Schafer MJ (2024) Aging and senescent fates of oligodendrocyte precursor cells in the mouse brain. Npj Aging 10(1):47","journal-title":"Npj Aging"},{"issue":"3","key":"2012_CR115","doi-asserted-by":"publisher","first-page":"e0246157","DOI":"10.1371\/journal.pone.0246157","volume":"16","author":"DS Goodin","year":"2021","unstructured":"Goodin DS, Khankhanian P, Gourraud PA, Vince N (2021) The nature of genetic and environmental susceptibility to multiple sclerosis. PLoS ONE 16(3):e0246157","journal-title":"PLoS ONE"},{"key":"2012_CR116","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nri2550","volume":"9","author":"J Goverman","year":"2009","unstructured":"Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393\u2013407","journal-title":"Nat Rev Immunol"},{"key":"2012_CR117","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2011.01016.x","author":"JM Goverman","year":"2011","unstructured":"Goverman JM, Goverman J (2011) Immune tolerance in multiple sclerosis. Immunol Rev. https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01016.x","journal-title":"Immunol Rev"},{"issue":"2","key":"2012_CR118","doi-asserted-by":"publisher","first-page":"e0228883","DOI":"10.1371\/journal.pone.0228883","volume":"15","author":"M Graner","year":"2020","unstructured":"Graner M, Pointon T, Manton S, Green M, Dennison K, Davis M et al (2020) Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides. PLoS ONE 15(2):e0228883","journal-title":"PLoS ONE"},{"key":"2012_CR119","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4103\/1673-5374.245462","volume":"14","author":"Y Guan","year":"2019","unstructured":"Guan Y, Jakimovski D, Ramanathan M, Weinstock-Guttman B, Zivadinov R (2019) The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging. Neural Regen Res 14:373\u2013386","journal-title":"Neural Regen Res"},{"key":"2012_CR120","doi-asserted-by":"publisher","first-page":"711564","DOI":"10.3389\/fncir.2021.711564","volume":"15","author":"C Guo","year":"2021","unstructured":"Guo C, Ma YY (2021) Calcium permeable-AMPA receptors and excitotoxicity in neurological disorders. Front Neural Circuits 15:711564","journal-title":"Front Neural Circuits"},{"key":"2012_CR121","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s40273-014-0150-1","volume":"32","author":"S Guo","year":"2014","unstructured":"Guo S, Pelligra C, Saint-Laurent Thibault C, Hernandez L, Kansal A (2014) Cost-effectiveness analyses in multiple sclerosis: a review of modelling approaches. Pharmacoeconomics 32:559\u2013572","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"2012_CR122","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/WCO.0000000000000326","volume":"29","author":"M Hagens","year":"2016","unstructured":"Hagens M, van Berckel B, Barkhof F (2016) Novel MRI and PET markers of neuroinflammation in multiple sclerosis. Curr Opinion Neurol 29(3):229\u2013236","journal-title":"Curr Opinion Neurol"},{"issue":"2","key":"2012_CR123","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/msj.20246","volume":"78","author":"JD Haines","year":"2011","unstructured":"Haines JD, Inglese M, Casaccia P (2011) Axonal damage in multiple sclerosis. Mount Sinai J Med 78(2):231\u2013243","journal-title":"Mount Sinai J Med"},{"issue":"6","key":"2012_CR124","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1007\/s00415-020-10373-w","volume":"268","author":"K Hares","year":"2021","unstructured":"Hares K, Kemp K, Loveless S, Rice CM, Scolding N, Tallantyre E et al (2021) KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis. J Neurol 268(6):2175\u20132184","journal-title":"J Neurol"},{"key":"2012_CR125","doi-asserted-by":"publisher","first-page":"1425706","DOI":"10.3389\/fimmu.2024.1425706","volume":"15","author":"A Haroon","year":"2024","unstructured":"Haroon A, Seerapu H, Fang LP, We\u00df JH, Bai X (2024) Unlocking the potential: immune functions of oligodendrocyte precursor cells. Front Immunol 15:1425706","journal-title":"Front Immunol"},{"key":"2012_CR126","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae359","author":"DM Harrison","year":"2024","unstructured":"Harrison DM, Sati P, Klawiter EC, Narayanan S, Bagnato F, Beck ES et al (2024) The use of 7T MRI in multiple sclerosis: review and consensus statement from the north American imaging in multiple sclerosis cooperative. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcae359","journal-title":"Brain Commun"},{"issue":"1","key":"2012_CR127","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/01616412.2021.1952511","volume":"44","author":"HK Hassoun","year":"2022","unstructured":"Hassoun HK, Al-Mahadawi A, Sheaheed NM, Sami SM, Jamal A, Allebban Z (2022) Epidemiology of multiple sclerosis in Iraq: retrospective review of 4355 cases and literature review. Neurol Res 44(1):14\u201323","journal-title":"Neurol Res"},{"issue":"3","key":"2012_CR128","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa1601277","volume":"376","author":"SL Hauser","year":"2017","unstructured":"Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B et al (2017) Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis. N Engl J Med 376(3):221\u2013234","journal-title":"N Engl J Med"},{"issue":"6","key":"2012_CR129","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa1917246","volume":"383","author":"SL Hauser","year":"2020","unstructured":"Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK et al (2020) Ofatumumab versus teriflunomide in multiple sclerosis. N Engl J Med 383(6):546\u2013557","journal-title":"N Engl J Med"},{"key":"2012_CR130","doi-asserted-by":"publisher","first-page":"1212676","DOI":"10.3389\/fimmu.2023.1212676","volume":"14","author":"AK Hedstr\u00f6m","year":"2023","unstructured":"Hedstr\u00f6m AK (2023) Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection. Front Immunol 14:1212676","journal-title":"Front Immunol"},{"issue":"10","key":"2012_CR131","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s10654-017-0250-2","volume":"32","author":"AK Hedstr\u00f6m","year":"2017","unstructured":"Hedstr\u00f6m AK, Katsoulis M, H\u00f6ssjer O, Bomfim IL, Oturai A, Sondergaard HB et al (2017) The interaction between smoking and HLA genes in multiple sclerosis: replication and refinement. Eur J Epidemiol 32(10):909\u2013919","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"2012_CR132","doi-asserted-by":"publisher","first-page":"a028969","DOI":"10.1101\/cshperspect.a028969","volume":"8","author":"CC Hemond","year":"2018","unstructured":"Hemond CC, Bakshi R (2018) Magnetic resonance imaging in multiple sclerosis. Cold Spring Harbor Perspect Med 8(5):a028969","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"17","key":"2012_CR133","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.3390\/nu16172922","volume":"16","author":"D Hinojosa-Nogueira","year":"2024","unstructured":"Hinojosa-Nogueira D, Subiri-Verdugo A, D\u00edaz-Perdigones CM, Rodr\u00edguez-Mu\u00f1oz A, Vilches-P\u00e9rez A, Mela V et al (2024) Precision or personalized nutrition: a bibliometric analysis. Nutrients 16(17):2922","journal-title":"Nutrients"},{"key":"2012_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.587078","author":"G Houen","year":"2020","unstructured":"Houen G, Trier NH, Frederiksen JL (2020) Epstein-Barr virus and multiple sclerosis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.587078","journal-title":"Front Immunol"},{"key":"2012_CR135","doi-asserted-by":"publisher","first-page":"103166","DOI":"10.1016\/j.critrevonc.2020.103166","volume":"157","author":"Z Hu","year":"2021","unstructured":"Hu Z, Chen H, Long Y, Li P, Gu Y (2021) The main sources of circulating cell-free DNA: apoptosis, necrosis and active secretion. Crit Rev Oncol\/hematol 157:103166","journal-title":"Crit Rev Oncol\/hematol"},{"key":"2012_CR136","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jneuroim.2016.04.014","volume":"295\u2013296","author":"Q Huang","year":"2016","unstructured":"Huang Q, Xiao B, Ma X, Qu M, Li Y, Nagarkatti P et al (2016) MicroRNAs associated with the pathogenesis of multiple sclerosis. J Neuroimmunol 295\u2013296:148\u2013161","journal-title":"J Neuroimmunol"},{"issue":"6","key":"2012_CR137","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.3892\/etm.2017.4410","volume":"13","author":"WJ Huang","year":"2017","unstructured":"Huang WJ, Chen WW, Zhang X (2017) Multiple sclerosis: pathology, diagnosis and treatments. Exp Ther Med 13(6):3163\u20133166","journal-title":"Exp Ther Med"},{"key":"2012_CR138","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S1474-4422(12)70309-5","volume":"12","author":"JL Huynh","year":"2013","unstructured":"Huynh JL, Casaccia P (2013) Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment. Lancet Neurol 12:195\u2013206","journal-title":"Lancet Neurol"},{"issue":"1","key":"2012_CR139","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nn.3588","volume":"17","author":"JL Huynh","year":"2014","unstructured":"Huynh JL, Garg P, Thin TH, Yoo S, Dutta R, Trapp BD et al (2014) Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains. Nat Neurosci 17(1):121\u2013130","journal-title":"Nat Neurosci"},{"key":"2012_CR140","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s12276-020-0435-8","volume":"52","author":"JR Hwang","year":"2020","unstructured":"Hwang JR, Byeon Y, Kim D, Park SG (2020) Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development. Exp Mol Med 52:750\u2013761","journal-title":"Exp Mol Med"},{"issue":"1","key":"2012_CR141","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12883-019-1577-y","volume":"19","author":"D Imani","year":"2019","unstructured":"Imani D, Razi B, Motallebnezhad M, Rezaei R (2019) Association between vitamin D receptor (VDR) polymorphisms and the risk of multiple sclerosis (MS): an updated meta-analysis. BMC Neurol 19(1):339","journal-title":"BMC Neurol"},{"key":"2012_CR142","doi-asserted-by":"crossref","unstructured":"Iorio M V, Croce CM (2012). Causes and consequences of MicroRNA Dysregulation [Internet]. Available from: www.journalppo.com","DOI":"10.1097\/PPO.0b013e318250c001"},{"key":"2012_CR143","doi-asserted-by":"crossref","unstructured":"De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A. Integrating risk factors HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis [Internet]. 2008. Available from: www.neurology.org.","DOI":"10.1212\/01.wnl.0000294325.63006.f8"},{"key":"2012_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00129","author":"F Jagot","year":"2016","unstructured":"Jagot F, Davoust N (2016) Is it worth considering circulating microRNAs in multiple sclerosis? Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2016.00129","journal-title":"Front Immunol"},{"key":"2012_CR145","doi-asserted-by":"publisher","first-page":"983023","DOI":"10.3389\/fonc.2023.983023","volume":"13","author":"S Jain","year":"2023","unstructured":"Jain S, Dhingra VK (2023) An overview of radiolabeled amino acid tracers in oncologic imaging. Front Oncol 13:983023","journal-title":"Front Oncol"},{"key":"2012_CR146","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/00207454.2020.1732974","volume":"131","author":"K Jamebozorgi","year":"2021","unstructured":"Jamebozorgi K, Rostami D, Pormasoumi H, Taghizadeh E, Barreto GE, Sahebkar A (2021) Epigenetic aspects of multiple sclerosis and future therapeutic options. Int J Neurosci 131:56\u201364","journal-title":"Int J Neurosci"},{"key":"2012_CR147","doi-asserted-by":"publisher","first-page":"40","DOI":"10.29245\/2578-3009\/2021\/2.1216","volume":"5","author":"LM James","year":"2021","unstructured":"James LM, Georgopoulos AP (2021) Immunogenetic epidemiology of multiple sclerosis in 14 continental western European countries. J Immunol Sci 5:40\u201346","journal-title":"J Immunol Sci"},{"key":"2012_CR148","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12084","author":"S Jarius","year":"2013","unstructured":"Jarius S, Wildemann B (2013) Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature. Brain Pathol. https:\/\/doi.org\/10.1111\/bpa.12084","journal-title":"Brain Pathol"},{"issue":"7","key":"2012_CR149","doi-asserted-by":"publisher","first-page":"282","DOI":"10.21037\/atm-21-3073","volume":"11","author":"H Jin","year":"2023","unstructured":"Jin H, Lu Q, Gao F, Hao H (2023) Application of oligoclonal bands and other cerebrospinal fluid variables in multiple sclerosis and other neuroimmunological diseases: a narrative review. Ann Transl Med 11(7):282\u2013282","journal-title":"Ann Transl Med"},{"key":"2012_CR150","first-page":"106","volume":"1","author":"NR Jog","year":"2020","unstructured":"Jog NR, McClain MT, Heinlen LD, Gross T, Towner R, Guthridge JM et al (2020) Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model. J Autoimmun 1:106","journal-title":"J Autoimmun"},{"issue":"11","key":"2012_CR151","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrneurol.2010.151","volume":"6","author":"N Jones","year":"2010","unstructured":"Jones N (2010) Multiple sclerosis: HLA B*44 is protective in multiple sclerosis. Nat Rev Neurol 6(11):584","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"2012_CR152","first-page":"993","volume":"2","author":"DR Kaimen-Maciel","year":"2009","unstructured":"Kaimen-Maciel DR, Reiche EMV, Borelli SD, Morimoto HK, Melo FC, Lopes J, Dorigon RF, Cavalet C, Yamaguchi EM, Silveira TL, Da Silva WV (2009) HLA-DRB1* allele-associated genetic susceptibility and protection against multiple sclerosis in Brazilian patients. Mol Med Rep 2(6):993\u2013998","journal-title":"Mol Med Rep"},{"key":"2012_CR153","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2147\/EB.S54131","volume":"8","author":"N Kale","year":"2016","unstructured":"Kale N (2016) Optic neuritis as an early sign of multiple sclerosis. Eye Brain 8:195\u2013202","journal-title":"Eye Brain"},{"issue":"5","key":"2012_CR154","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMoa0909494","volume":"362","author":"L Kappos","year":"2010","unstructured":"Kappos L, Radue EW, O\u2019Connor P, Polman C, Hohlfeld R, Calabresi P et al (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 362(5):387\u2013401","journal-title":"N Engl J Med"},{"issue":"10127","key":"2012_CR155","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S0140-6736(18)30475-6","volume":"391","author":"L Kappos","year":"2018","unstructured":"Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R et al (2018) Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study. Lancet 391(10127):1263\u20131273","journal-title":"Lancet"},{"key":"2012_CR156","doi-asserted-by":"crossref","unstructured":"Kappos L, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, et al 2009. Articles Long-term eff ect of early treatment with interferon beta-1b after a fi rst clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. www.thelancet.com\/neurology [Internet]. 8. Available from: www.thelancet.com\/neurology","DOI":"10.1016\/S1474-4422(09)70237-6"},{"issue":"4","key":"2012_CR157","doi-asserted-by":"publisher","first-page":"029025","DOI":"10.1101\/cshperspect.a029025","volume":"8","author":"BJ Kaskow","year":"2018","unstructured":"Kaskow BJ, Baecher-Allan C (2018) Effector t cells in multiple sclerosis. Cold Spring Harb Perspect Med 8(4):029025","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2012_CR158","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T et al (2018) Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 14:577\u2013589","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"2012_CR159","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41598-021-04490-3","volume":"12","author":"M Kim","year":"2022","unstructured":"Kim M, Choi KS, Hyun RC, Hwang I, Yun TJ, Kim SM et al (2022) Free-water diffusion tensor imaging detects occult periependymal abnormality in the AQP4-IgG-seropositive neuromyelitis optica spectrum disorder. Sci Rep 12(1):512","journal-title":"Sci Rep"},{"issue":"1","key":"2012_CR160","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00401-016-1559-8","volume":"132","author":"S Kinzel","year":"2016","unstructured":"Kinzel S, Lehmann-Horn K, Torke S, H\u00e4usler D, Winkler A, Stadelmann C et al (2016) Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen. Acta Neuropathol 132(1):43\u201358","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2012_CR161","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1038\/s41467-019-11638-3","volume":"10","author":"L Kirby","year":"2019","unstructured":"Kirby L, Jin J, Cardona JG, Smith MD, Martin KA, Wang J et al (2019) Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. Nat Commun 10(1):3887","journal-title":"Nat Commun"},{"key":"2012_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.604049","author":"I Kleerekooper","year":"2020","unstructured":"Kleerekooper I, Houston S, Dubis AM, Trip SA, Petzold A (2020) Optical coherence tomography angiography (OCTA) in multiple sclerosis and neuromyelitis optica spectrum disorder. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2020.604049","journal-title":"Front Neurol"},{"issue":"6","key":"2012_CR163","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.4049\/jimmunol.1100626","volume":"187","author":"DM Kofler","year":"2011","unstructured":"Kofler DM, Severson CA, Mousissian N, De Jager PL, Hafler DA (2011) The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation. J Immunol 187(6):3286\u20133291","journal-title":"J Immunol"},{"issue":"1","key":"2012_CR164","doi-asserted-by":"publisher","first-page":"e01194","DOI":"10.1002\/brb3.1194","volume":"9","author":"M Kolasa","year":"2019","unstructured":"Kolasa M, Hakulinen U, Brander A, Hagman S, Dastidar P, Elovaara I, Sumelahti ML (2019) Diffusion tensor imaging and disability progression in multiple sclerosis: a 4-year follow-up study. Brain Behav 9(1):e01194","journal-title":"Brain Behav"},{"key":"2012_CR165","doi-asserted-by":"publisher","first-page":"912005","DOI":"10.3389\/fimmu.2022.912005","volume":"13","author":"RA K\u00f6lliker Frers","year":"2022","unstructured":"K\u00f6lliker Frers RA, Otero-Losada M, Kobiec T, Udovin LD, Aon Bertolino ML, Herrera MI, Capani F (2022) Multidimensional overview of neurofilament light chain contribution to comprehensively understanding multiple sclerosis. Front Immunol 13:912005","journal-title":"Front Immunol"},{"issue":"1","key":"2012_CR166","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00296-023-05499-9","volume":"44","author":"J Kosa\u0142ka-W\u0119giel","year":"2024","unstructured":"Kosa\u0142ka-W\u0119giel J, Licho\u0142ai S, Pacholczak-Madej R, Dziedzina S, Milewski M, Kuszmiersz P et al (2024) Serum IL-17 and TNF\u03b1 as prognostic biomarkers in systemic sclerosis patients: a prospective study. Rheumatol Int 44(1):119\u2013128","journal-title":"Rheumatol Int"},{"key":"2012_CR167","unstructured":"Kouchaki E, Dashti F, Mirazimi SMA, Alirezaei Z, Jafari SH, Hamblin MR, et al 2021. Neurofilament light chain as a biomarker for diagnosis of multiple sclerosis. EXCLI J. 20:1308\u201325. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34602928"},{"issue":"24","key":"2012_CR168","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1212\/WNL.0000000000004716","volume":"89","author":"K Kowalec","year":"2017","unstructured":"Kowalec K, McKay KA, Patten SB, Fisk JD, Evans C, Tremlett H et al (2017) Comorbidity increases the risk of relapse in multiple sclerosis. Neurology 89(24):2455\u20132461","journal-title":"Neurology"},{"issue":"10","key":"2012_CR169","doi-asserted-by":"publisher","first-page":"E1007","DOI":"10.1212\/WNL.0000000000007032","volume":"92","author":"J Kuhle","year":"2019","unstructured":"Kuhle J, Kropshofer H, Haering DA, Kundu U, Meinert R, Barro C et al (2019) Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology 92(10):E1007\u2013E1015","journal-title":"Neurology"},{"key":"2012_CR170","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann T, Moccia M, Coetzee T, Cohen JA, Correale J, Graves J et al (2023) Multiple sclerosis progression: time for a new mechanism-driven framework. Lancet Neurol 22:78\u201388","journal-title":"Lancet Neurol"},{"key":"2012_CR171","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/joim.13045","volume":"288","author":"L Kular","year":"2020","unstructured":"Kular L, Jagodic M (2020) Epigenetic insights into multiple sclerosis disease progression. J Intern Med 288:82\u2013102","journal-title":"J Intern Med"},{"issue":"1","key":"2012_CR172","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1038\/s41467-018-04732-5","volume":"9","author":"L Kular","year":"2018","unstructured":"Kular L, Liu Y, Ruhrmann S, Zheleznyakova G, Marabita F, Gomez-Cabrero D et al (2018) DNA methylation as a mediator of HLA-DRB1 15:01 and a protective variant in multiple sclerosis. Nat Commun 9(1):2397","journal-title":"Nat Commun"},{"key":"2012_CR173","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s40495-017-0117-y","volume":"4","author":"AI Lalani","year":"2018","unstructured":"Lalani AI, Zhu S, Gokhale S, Jin J, Xie P (2018) Traf molecules in inflammation and inflammatory diseases. Curr Pharmacol Rep 4:64\u201390","journal-title":"Curr Pharmacol Rep"},{"issue":"4","key":"2012_CR174","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/acn3.51326","volume":"8","author":"A Langer-Gould","year":"2021","unstructured":"Langer-Gould A, Klocke S, Beaber B, Brara SM, Debacker J, Ayeni O et al (2021) Improving quality, affordability, and equity of multiple sclerosis care. Ann Clin Transl Neurol 8(4):980\u2013991","journal-title":"Ann Clin Transl Neurol"},{"key":"2012_CR175","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1586\/ern.10.7","volume":"10","author":"K Lauer","year":"2010","unstructured":"Lauer K (2010) Environmental risk factors in multiple sclerosis. Expert Rev Neurother 10:421\u2013440","journal-title":"Expert Rev Neurother"},{"key":"2012_CR176","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/eji.201646716","volume":"47","author":"PW Lee","year":"2017","unstructured":"Lee PW, Severin ME, Lovett-Racke AE (2017) TGF-\u03b2 regulation of encephalitogenic and regulatory T cells in multiple sclerosis. Eur J Immunol 47:446\u2013453","journal-title":"Eur J Immunol"},{"issue":"3","key":"2012_CR177","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1172\/JCI115072","volume":"87","author":"JM Lemire","year":"1991","unstructured":"Lemire JM, Clay Archer D (1991) 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87(3):1103\u20131107","journal-title":"J Clin Invest"},{"issue":"10","key":"2012_CR178","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3390\/biom12101476","volume":"12","author":"P Lewandowski","year":"2022","unstructured":"Lewandowski P, Go\u0142awski M, Baron M, Reichman-Warmusz E, Wojnicz R (2022) A systematic review of miRNA and cfDNA as potential biomarkers for liquid biopsy in myocarditis and inflammatory dilated cardiomyopathy. Biomolecules 12(10):1476","journal-title":"Biomolecules"},{"issue":"1\u20132","key":"2012_CR179","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jneuroim.2005.02.010","volume":"163","author":"L Leyva","year":"2005","unstructured":"Leyva L, Fern\u00e1ndez O, Fedetz M, Blanco E, Fern\u00e1ndez VE, Oliver B et al (2005) IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response. J Neuroimmunol 163(1\u20132):165\u2013171","journal-title":"J Neuroimmunol"},{"key":"2012_CR180","doi-asserted-by":"crossref","unstructured":"Li DKB, Held U, Petkau J, Daumer M, Barkhof F, Fazekas F et al (2006). MRI T2 lesion burden in multiple sclerosis a plateauing relationship with clinical disability [Internet]. Available from: www.neurology.org","DOI":"10.1212\/01.wnl.0000210506.00078.5c"},{"issue":"1\u20132","key":"2012_CR181","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jns.2009.12.018","volume":"290","author":"T Liggett","year":"2010","unstructured":"Liggett T, Melnikov A, Tilwalli S, Yi Q, Chen H, Replogle C et al (2010) Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis. J Neurol Sci 290(1\u20132):16\u201321","journal-title":"J Neurol Sci"},{"issue":"2","key":"2012_CR182","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s00415-020-10194-x","volume":"268","author":"LMP Lo","year":"2021","unstructured":"Lo LMP, Taylor BV, Winzenberg T, Palmer AJ, Blizzard L, van der Mei I (2021) Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis. J Neurol 268(2):602\u2013612","journal-title":"J Neurol"},{"issue":"6","key":"2012_CR183","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/medicina55060245","volume":"55","author":"B Lo Sasso","year":"2019","unstructured":"Lo Sasso B, Agnello L, Bivona G, Bellia C, Ciaccio M (2019) Cerebrospinal fluid analysis in multiple sclerosis diagnosis: an update. Medicina 55(6):245","journal-title":"Medicina"},{"issue":"1","key":"2012_CR184","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1038\/s41598-023-30502-5","volume":"13","author":"E Lopez-Soley","year":"2023","unstructured":"Lopez-Soley E, Martinez-Heras E, Solana E, Solanes A, Radua J, Vivo F et al (2023) Diffusion tensor imaging metrics associated with future disability in multiple sclerosis. Sci Rep 13(1):3565","journal-title":"Sci Rep"},{"issue":"11","key":"2012_CR185","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1002\/eji.201444662","volume":"44","author":"A Lossius","year":"2014","unstructured":"Lossius A, Johansen JN, Vartdal F, Robins H, \u0160altyte BJ, Holm\u00f8y T et al (2014) High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells. Eur J Immunol 44(11):3439\u20133452","journal-title":"Eur J Immunol"},{"issue":"2","key":"2012_CR186","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bbadis.2010.05.012","volume":"1812","author":"AE Lovett-Racke","year":"2011","unstructured":"Lovett-Racke AE, Yang Y, Racke MK (2011) Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? Biochim Et Biophys Acta (BBA) 1812(2):246\u2013251","journal-title":"Biochim Et Biophys Acta (BBA)"},{"key":"2012_CR187","doi-asserted-by":"publisher","unstructured":"Lu HC, Kim S, Steelman AJ, Tracy K, Zhou B, Michaud D, et al (2020) STAT3 signaling in myeloid cells promotes pathogenic myelin-specific T cell differentiation and autoimmune demyelination. https:\/\/doi.org\/10.1073\/pnas.191399711","DOI":"10.1073\/pnas.191399711"},{"key":"2012_CR188","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/925135","author":"RV Luckheeram","year":"2012","unstructured":"Luckheeram RV, Zhou R, Verma AD, Xia B (2012) CD4 +T cells: differentiation and functions. Clin Dev Immunol. https:\/\/doi.org\/10.1155\/2012\/925135","journal-title":"Clin Dev Immunol"},{"issue":"4","key":"2012_CR189","doi-asserted-by":"publisher","first-page":"e200270","DOI":"10.1212\/NXI.0000000000200270","volume":"11","author":"JD Lunemann","year":"2024","unstructured":"Lunemann JD, Hegen H, Villar LM, Rejdak K, Sao-Aviles A, Carbonell-Mirabent P et al (2024) Association of complement factors with disability progression in primary progressive multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 11(4):e200270","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"2012_CR190","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1017\/cjn.2019.329","volume":"47","author":"AP Lysandropoulos","year":"2020","unstructured":"Lysandropoulos AP, Perrotta G, Billiet T, Ribbens A, Du Pasquier R, Pot Kreis C et al (2020) Human leukocyte antigen genotype as a marker of multiple sclerosis prognosis. Can J Neurol Sci 47(2):189\u2013196","journal-title":"Can J Neurol Sci"},{"key":"2012_CR191","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1199313","author":"K Maciak","year":"2023","unstructured":"Maciak K, Dziedzic A, Saluk J (2023) Remyelination in multiple sclerosis from the miRNA perspective. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2023.1199313","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"2012_CR192","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1038\/s41467-019-09773-y","volume":"10","author":"L Madireddy","year":"2019","unstructured":"Madireddy L, Patsopoulos NA, Cotsapas C, Bos SD, Beecham A, McCauley J et al (2019) A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis. Nat Commun 10(1):2236","journal-title":"Nat Commun"},{"key":"2012_CR193","doi-asserted-by":"publisher","DOI":"10.1177\/2055217319881775","author":"Z Maghbooli","year":"2020","unstructured":"Maghbooli Z, Sahraian MA, Naser Moghadasi A (2020) Multiple sclerosis and human leukocyte antigen genotypes: focus on the middle east and north Africa region. Mult Scler J. https:\/\/doi.org\/10.1177\/2055217319881775","journal-title":"Mult Scler J"},{"issue":"1","key":"2012_CR194","doi-asserted-by":"publisher","first-page":"9403","DOI":"10.1038\/s41467-024-53658-8","volume":"15","author":"C Maguire","year":"2024","unstructured":"Maguire C, Wang C, Ramasamy A, Fonken C, Morse B, Lopez N et al (2024) Molecular mimicry as a mechanism of viral immune evasion and autoimmunity. Nat Commun 15(1):9403","journal-title":"Nat Commun"},{"key":"2012_CR195","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3389\/fneur.2020.00851","volume":"11","author":"M Magyari","year":"2020","unstructured":"Magyari M, Sorensen PS (2020) Comorbidity in multiple sclerosis. Front Neurol 11:851","journal-title":"Front Neurol"},{"key":"2012_CR196","first-page":"10","volume":"17","author":"A Mamedov","year":"2020","unstructured":"Mamedov A, Vorobyeva N, Filimonova I, Zakharova M, Kiselev I, Bashinskaya V et al (2020) Protective Allele for multiple sclerosis HLA-DRB1*01:01 provides kinetic discrimination of myelin and exogenous antigenic peptides. Front Immunol 17:10","journal-title":"Front Immunol"},{"key":"2012_CR197","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrneurol.2017.33","volume":"13","author":"RA Marrie","year":"2017","unstructured":"Marrie RA (2017) Comorbidity in multiple sclerosis: implications for patient care. Nat Rev Neurol 13:375\u2013382","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"2012_CR198","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1212\/01.wnl.0000333252.78173.5f","volume":"72","author":"RA Marrie","year":"2009","unstructured":"Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T (2009) Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology 72(2):117\u2013124","journal-title":"Neurology"},{"key":"2012_CR199","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181d6b125","author":"RA Marrie","year":"2010","unstructured":"Marrie RA, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D et al (2010) Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology. https:\/\/doi.org\/10.1212\/WNL.0b013e3181d6b125","journal-title":"Neurology"},{"key":"2012_CR200","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1352458514564491","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Cohen J, Stuve O, Trojano M, S\u00f8rensen PS, Reingold S et al (2015a) A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler J 21:263\u2013281","journal-title":"Mult Scler J"},{"key":"2012_CR201","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1177\/1352458514564485","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Reider N, Cohen J, Stuve O, Trojano M, Cutter G et al (2015b) A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis. Mult Scler J 21:318\u2013331","journal-title":"Mult Scler J"},{"key":"2012_CR202","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/1352458514564487","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Reingold S, Cohen J, Stuve O, Trojano M, Sorensen PS et al (2015c) The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler J 21:305\u2013317","journal-title":"Mult Scler J"},{"key":"2012_CR203","doi-asserted-by":"crossref","unstructured":"Marrie RA, Fisk J, Tremlett H, Wolfson C, Warren S, Blanchard J, et al 2016. Neurology \u00ae clinical practice differing trends in the incidence of vascular comorbidity in MS and the general population [Internet]. Vol. 6, Neurol Clin Pract. Available from: https:\/\/www.neurology.org","DOI":"10.1212\/CPJ.0000000000000230"},{"issue":"5","key":"2012_CR204","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3390\/nu12051248","volume":"12","author":"PJ Martens","year":"2020","unstructured":"Martens PJ, Gysemans C, Verstuyf A, Mathieu C (2020) Vitamin d\u2019s effect on immune function. Nutrients 12(5):1248","journal-title":"Nutrients"},{"issue":"9","key":"2012_CR205","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1136\/jnnp-2018-319190","volume":"90","author":"SJ Martin","year":"2019","unstructured":"Martin SJ, McGlasson S, Hunt D, Overell J (2019) Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies. J Neurol Neurosurg Psychiatry 90(9):1059\u20131067","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1\u20132","key":"2012_CR206","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jneuroim.2007.06.018","volume":"189","author":"A Mart\u00ednez","year":"2007","unstructured":"Mart\u00ednez A, Mas A, de las Heras V, Bartolom\u00e9 M, Arroyo R, Fern\u00e1ndez-Arquero M et al (2007) FcRL3 and multiple sclerosis pathogenesis: role in autoimmunity? J Neuroimmunol 189(1\u20132):132\u2013136","journal-title":"J Neuroimmunol"},{"key":"2012_CR207","doi-asserted-by":"publisher","first-page":"606","DOI":"10.4103\/1673-5374.266905","volume":"15","author":"B Martinez","year":"2020","unstructured":"Martinez B, Peplow P (2020) Micrornas in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression. Neural Regen Res 15:606\u2013619","journal-title":"Neural Regen Res"},{"issue":"1\u20132","key":"2012_CR208","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0165-5728(95)00023-U","volume":"59","author":"M Matsuda","year":"1995","unstructured":"Matsuda M, Tsukada N, Miyagi K, Yanagisawa N (1995) Increased levels of soluble vascular cell adhesion molecule-1 (VCAM-1) in the cerebrospinal fluid and sera of patients with multiple sclerosis and human T lymphotropic virus type-1-associated myelopathy. J Neuroimmunol 59(1\u20132):35\u201340","journal-title":"J Neuroimmunol"},{"issue":"1","key":"2012_CR209","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1038\/s41598-017-03536-9","volume":"7","author":"A Maver","year":"2017","unstructured":"Maver A, Lavtar P, Risti\u0107 S, Stopin\u0161ek S, Sim\u010di\u010d S, Ho\u010devar K et al (2017) Identification of rare genetic variation of NLRP1 gene in familial multiple sclerosis. Sci Rep 7(1):3715","journal-title":"Sci Rep"},{"issue":"1","key":"2012_CR210","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12974-024-03193-6","volume":"21","author":"V Mazziotti","year":"2024","unstructured":"Mazziotti V, Crescenzo F, Turano E, Guandalini M, Bertolazzo M, Ziccardi S et al (2024) The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse? J Neuroinflamm 21(1):209","journal-title":"J Neuroinflamm"},{"key":"2012_CR211","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0065-2776(08)00404-5","volume":"98","author":"KA McLaughlin","year":"2008","unstructured":"McLaughlin KA, Wucherpfennig KW (2008) B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases. Adv Immunol 98:121\u2013149","journal-title":"Adv Immunol"},{"issue":"1","key":"2012_CR212","doi-asserted-by":"publisher","first-page":"e1583","DOI":"10.1002\/wsbm.1583","volume":"15","author":"GM Mey","year":"2023","unstructured":"Mey GM, Mahajan KR, DeSilva TM (2023) Neurodegeneration in multiple sclerosis. Wires Mechan Dis 15(1):e1583.\u00a0https:\/\/doi.org\/10.1002\/wsbm.1583","journal-title":"Wires Mechan Dis"},{"issue":"6","key":"2012_CR213","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ana.24398","volume":"77","author":"I Michailidou","year":"2015","unstructured":"Michailidou I, Willems JGP, Kooi EJ, Van Eden C, Gold SM, Geurts JJG et al (2015) Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus. Ann Neurol 77(6):1007\u20131026","journal-title":"Ann Neurol"},{"issue":"10","key":"2012_CR214","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1093\/brain\/awm198","volume":"130","author":"Y Mikaeloff","year":"2007","unstructured":"Mikaeloff Y, Caridade G, Tardieu M, Suissa S (2007) Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain 130(10):2589\u20132595","journal-title":"Brain"},{"issue":"3","key":"2012_CR215","first-page":"309","volume":"12","author":"MH Mirzaii-Dizgah","year":"2021","unstructured":"Mirzaii-Dizgah MH, Mirzaii-Dizgah MR, Mirzaii-Dizgah I (2021) Serum and saliva myelin basic protein as multiple sclerosis biomarker. Basic Clin Neurosci 12(3):309\u2013314","journal-title":"Basic Clin Neurosci"},{"issue":"1","key":"2012_CR216","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41435-017-0009-5","volume":"20","author":"MK Misra","year":"2019","unstructured":"Misra MK, Damotte V, Hollenbach JA (2019) Structure-based selection of human metabolite binding P4 pocket of DRB1*15:01 and DRB1*15:03, with implications for multiple sclerosis. Genes Immun 20(1):46\u201355","journal-title":"Genes Immun"},{"issue":"1","key":"2012_CR217","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12974-023-02763-4","volume":"20","author":"S Mohammadi","year":"2023","unstructured":"Mohammadi S, Gouravani M, Salehi MA, Arevalo JF, Galetta SL, Harandi H et al (2023) Optical coherence tomography angiography measurements in multiple sclerosis: a systematic review and meta-analysis. J Neuroinflamm 20(1):85","journal-title":"J Neuroinflamm"},{"key":"2012_CR218","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2911386","author":"EMA Mohammed","year":"2024","unstructured":"Mohammed EMA (2024) Understanding multiple sclerosis pathophysiology and current disease-modifying therapies: a review of unaddressed aspects. Front Biosci-Landmark. https:\/\/doi.org\/10.31083\/j.fbl2911386","journal-title":"Front Biosci-Landmark"},{"issue":"2","key":"2012_CR219","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1352458517751049","volume":"24","author":"X Montalban","year":"2018","unstructured":"Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D et al (2018) ECTRIMS\/EAN guideline on the pharmacological treatment of people with multiple sclerosis. Mult Scler 24(2):96\u2013120","journal-title":"Mult Scler"},{"key":"2012_CR220","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01134","author":"A Moreau","year":"2019","unstructured":"Moreau A, Febvey O, Mognetti T, Frappaz D, Kryza D (2019) Contribution of different positron emission tomography tracers in glioma management: focus on glioblastoma. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2019.01134","journal-title":"Front Oncol"},{"issue":"1","key":"2012_CR221","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13548506.2010.521569","volume":"16","author":"RW Motl","year":"2011","unstructured":"Motl RW, McAuley E, Wynn D, Suh Y, Weikert M (2011) Effects of change in fatigue and depression on physical activity over time in relapsing-remitting multiple sclerosis. Psychol Health Med 16(1):1\u201311","journal-title":"Psychol Health Med"},{"key":"2012_CR222","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809323","author":"F Mouliere","year":"2018","unstructured":"Mouliere F, Mair R, Chandrananda D, Marass F, Smith CG, Su J et al (2018) Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients. EMBO Mol Med. https:\/\/doi.org\/10.15252\/emmm.201809323","journal-title":"EMBO Mol Med"},{"key":"2012_CR223","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00018-011-0872-6","volume":"69","author":"H Mouquet","year":"2012","unstructured":"Mouquet H, Nussenzweig MC (2012) Polyreactive antibodies in adaptive immune responses to viruses. Cell Mol Life Sci 69:1435\u20131445","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"2012_CR224","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/ana.23591","volume":"72","author":"EM Mowry","year":"2012","unstructured":"Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR et al (2012) Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol 72(2):234\u2013240","journal-title":"Ann Neurol"},{"issue":"7","key":"2012_CR225","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/jnr.20826","volume":"83","author":"G Muthian","year":"2006","unstructured":"Muthian G, Raikwar HP, Rajasingh J, Bright JJ (2006) 1, 25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12\/IFN\u03b3 axis leading to Th1 response in experimental allergic encephalomyelitis. J Neurosci Res 83(7):1299\u20131309","journal-title":"J Neurosci Res"},{"issue":"4","key":"2012_CR226","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/brain\/121.4.687","volume":"121","author":"LGJ Nijeholt","year":"1998","unstructured":"Nijeholt LGJ, Van Walderveen MAA, Castelijns JA, Van Waesberghe JHTM, Polman C et al (1998) Brain and spinal cord abnormalities in multiple sclerosis correlation between MRI parameters, clinical subtypes and symptoms. Brain 121(4):687\u2013697. https:\/\/doi.org\/10.1093\/brain\/121.4.687","journal-title":"Brain"},{"key":"2012_CR227","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9564","author":"K Nishanth","year":"2020","unstructured":"Nishanth K, Tariq E, Nzvere FP, Miqdad M, Cancarevic I (2020) Role of smoking in the pathogenesis of multiple sclerosis: a review article. Cureus. https:\/\/doi.org\/10.7759\/cureus.9564","journal-title":"Cureus"},{"issue":"11","key":"2012_CR228","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3390\/diagnostics14111120","volume":"14","author":"R Nistri","year":"2024","unstructured":"Nistri R, Ianniello A, Pozzilli V, Giann\u00ec C, Pozzilli C (2024) Advanced MRI techniques: diagnosis and follow-up of multiple sclerosis. Diagnostics 14(11):1120","journal-title":"Diagnostics"},{"issue":"11","key":"2012_CR229","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3390\/jpm13111524","volume":"13","author":"V Nociti","year":"2023","unstructured":"Nociti V, Romozzi M (2023) The importance of managing modifiable comorbidities in people with multiple sclerosis: a narrative review. J Personal Med 13(11):1524","journal-title":"J Personal Med"},{"key":"2012_CR230","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14040400","author":"V Nociti","year":"2024","unstructured":"Nociti V, Romozzi M, Mirabella M (2024) Challenges in diagnosis and therapeutic strategies in late-onset multiple sclerosis. J Pers Med. https:\/\/doi.org\/10.3390\/jpm14040400","journal-title":"J Pers Med"},{"key":"2012_CR231","doi-asserted-by":"crossref","unstructured":"Novakova L, Zetterberg H, Sundstr\u00f6m P, Axelsson M, Khademi M, Gunnarsson M, et al (2017). Monitoring disease activity in multiple sclerosis using serum neurofilament light protein [Internet]. Available from: https:\/\/www.neurology.org","DOI":"10.1212\/WNL.0000000000004683"},{"key":"2012_CR232","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/472790","volume":"2011","author":"S Noval","year":"2011","unstructured":"Noval S, Contreras I, Mu\u00f1oz S, Oreja-Guevara C, Manzano B, Rebolleda G (2011) Optical coherence tomography in multiple sclerosis and neuromyelitis optica: an update. Mult Scler Int 2011:1\u201311","journal-title":"Mult Scler Int"},{"key":"2012_CR233","doi-asserted-by":"publisher","first-page":"11718","DOI":"10.3390\/ijms130911718","volume":"13","author":"C O\u2019Gorman","year":"2012","unstructured":"O\u2019Gorman C, Lucas R, Taylor B (2012) Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci 13:11718\u201311752","journal-title":"Int J Mol Sci"},{"issue":"14","key":"2012_CR234","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMoa1014656","volume":"365","author":"P O'Connor","year":"2011","unstructured":"O\u2019Connor P, Wolinsky JS, Confavreux C, Comi G, Kappos L, Olsson TP et al (2011) Randomized trial of oral teriflunomide for relapsing multiple sclerosis. N Engl J Med 365(14):1293\u20131303","journal-title":"N Engl J Med"},{"key":"2012_CR235","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1007\/s43440-024-00642-0","volume":"76","author":"P Olejnik","year":"2024","unstructured":"Olejnik P, Roszkowska Z, Adamus S, Kasare\u0142\u0142o K (2024) Multiple sclerosis: a narrative overview of current pharmacotherapies and emerging treatment prospects. Pharmacol Rep 76:926\u2013943","journal-title":"Pharmacol Rep"},{"issue":"2","key":"2012_CR236","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1172\/JCI200113032","volume":"108","author":"JK Olson","year":"2001","unstructured":"Olson JK, Croxford JL, Calenoff MA, Dal Canto MC, Miller SD (2001) A virus-induced molecular mimicry model of multiple sclerosis. J Clin Investig 108(2):311\u2013318","journal-title":"J Clin Investig"},{"issue":"1","key":"2012_CR237","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","volume":"13","author":"T Olsson","year":"2017","unstructured":"Olsson T, Barcellos LF, Alfredsson L (2017) Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol 13(1):25\u201336","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"2012_CR238","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3390\/cimb45020094","volume":"45","author":"G Papiri","year":"2023","unstructured":"Papiri G, D\u2019Andreamatteo G, Cacchi\u00f2 G, Alia S, Silvestrini M, Paci C et al (2023) Multiple sclerosis: inflammatory and neuroglial aspects. Curr Issues Mol Biol 45(2):1443\u20131470","journal-title":"Curr Issues Mol Biol"},{"issue":"12","key":"2012_CR239","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.3390\/ijms25126295","volume":"25","author":"Y Park","year":"2024","unstructured":"Park Y, Kc N, Paneque A, Cole PD (2024) Tau, glial fibrillary acidic protein, and neurofilament light chain as brain protein biomarkers in cerebrospinal fluid and blood for diagnosis of neurobiological diseases. Int J Mol Sci 25(12):6295","journal-title":"Int J Mol Sci"},{"key":"2012_CR240","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3389\/fimmu.2017.00425","volume":"8","author":"GP Parnell","year":"2017","unstructured":"Parnell GP, Booth DR (2017) The multiple sclerosis (MS) genetic risk factors indicate both acquired and innate immune cell subsets contribute to MS pathogenesis and identify novel therapeutic opportunities. Front Immunol 8:425","journal-title":"Front Immunol"},{"issue":"6460","key":"2012_CR241","first-page":"7188","volume":"365","author":"NA Patsopoulos","year":"2019","unstructured":"Patsopoulos NA, Baranzini SE, Santaniello A, Shoostari P, Cotsapas C, Wong G et al (2019) Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science (1979) 365(6460):7188","journal-title":"Science (1979)"},{"issue":"3","key":"2012_CR242","doi-asserted-by":"publisher","first-page":"29058","DOI":"10.1101\/cshperspect.a029058","volume":"9","author":"A Paul","year":"2019","unstructured":"Paul A, Comabella M, Gandhi R (2019) Biomarkers in multiple sclerosis. Cold Spring Harb Perspect Med 9(3):29058","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"2012_CR243","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/1073858410381531","volume":"17","author":"MP Pender","year":"2011","unstructured":"Pender MP (2011) The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis. Neuroscientist 17(4):351\u2013367","journal-title":"Neuroscientist"},{"issue":"10","key":"2012_CR244","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1038\/cti.2014.25","volume":"3","author":"MP Pender","year":"2014","unstructured":"Pender MP, Burrows SR (2014) Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy. Clin Trans Immunol 3(10):e27","journal-title":"Clin Trans Immunol"},{"issue":"5","key":"2012_CR245","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.4049\/jimmunol.164.5.2405","volume":"164","author":"G Penna","year":"2000","unstructured":"Penna G, Adorini L (2000) 1\u03b1,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164(5):2405\u20132411","journal-title":"J Immunol"},{"issue":"3","key":"2012_CR246","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajhg.2024.01.013","volume":"111","author":"MDRB P\u00e9rez","year":"2024","unstructured":"P\u00e9rez MDRB, Jacobs EZ, Vantomme L, Leblanc P, Bogaert E, Dheedene A et al (2024) Haploinsufficiency of ZFHX3, encoding a key player in neuronal development, causes syndromic intellectual disability. Am J Hum Genet 111(3):509\u2013528","journal-title":"Am J Hum Genet"},{"key":"2012_CR247","doi-asserted-by":"crossref","unstructured":"P\u00e9rez S\u00e1nchez S, Madue\u00f1o SE, Rus Hidalgo M, Dom\u00ednguez Mayoral AM, Vilches-Arenas A, Navarro Mascarell G, et al (2021). Usefulness of optic nerve ultrasound to predict clinical progression in multiple sclerosis [Internet]. Neurolog\u00eda Vol. 36. Available from: www.elsevier.es\/neurologia","DOI":"10.1016\/j.nrleng.2017.12.010"},{"key":"2012_CR248","first-page":"37","volume":"1","author":"R Persson","year":"2020","unstructured":"Persson R, Lee S, Yood MU, Wagner M, Minton N, Niemcryk S et al (2020) Incident cardiovascular disease in patients diagnosed with multiple sclerosis: a multi-database study. Mult Scler Relat Disord 1:37","journal-title":"Mult Scler Relat Disord"},{"key":"2012_CR249","doi-asserted-by":"publisher","unstructured":"Pirko I, Noseworthy JH (2009) Demyelinating disorders of the central nervous system. Textbook of Clin Neurol 1103. https:\/\/doi.org\/10.1016\/B978-141603618-0.10048-7","DOI":"10.1016\/B978-141603618-0.10048-7"},{"key":"2012_CR250","doi-asserted-by":"crossref","unstructured":"Politis M, Giannetti P, Su P, Turkheimer F, Keihaninejad S, Wu K, et al (2012). Increased PK11195 PET binding in the cortex of patients with MS correlates with disability [Internet]. Available from: www.neurology.org","DOI":"10.1212\/WNL.0b013e3182635645"},{"key":"2012_CR251","doi-asserted-by":"crossref","unstructured":"Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic Criteria for Multiple Sclerosis: 2005 Revisions to the \u201cMcDonald Criteria.\u201d 2005; Available from: www.interscience.wiley.com","DOI":"10.1002\/ana.20703"},{"key":"2012_CR252","doi-asserted-by":"crossref","unstructured":"Polman CH, O\u2019connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, et al 2006. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med Vol. 354. Available from: www.nejm.org","DOI":"10.1056\/NEJMoa044397"},{"key":"2012_CR253","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fnmol.2016.00085","volume":"9","author":"P Poutiainen","year":"2016","unstructured":"Poutiainen P, Jaronen M, Quintana FJ, Brownell AL (2016) Precision medicine in multiple sclerosis: future of PET imaging of inflammation and reactive astrocytes. Front Mol Neurosci 9:85","journal-title":"Front Mol Neurosci"},{"key":"2012_CR254","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137354","author":"P Prapas","year":"2024","unstructured":"Prapas P, Anagnostouli M (2024) Macrophages and HLA-class II alleles in multiple sclerosis: insights in therapeutic dynamics. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25137354","journal-title":"Int J Mol Sci"},{"key":"2012_CR255","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/B978-0-12-800098-4.00006-4","volume":"88","author":"AM Price","year":"2014","unstructured":"Price AM, Luftig MA (2014) Dynamic epstein-barr virus gene expression on the path to B-cell transformation. Adv Virus Res 88:279\u2013313","journal-title":"Adv Virus Res"},{"key":"2012_CR256","doi-asserted-by":"publisher","unstructured":"PRISMS (Prevention of Relapses and Disability by Interferon-\u03b2-1a Subcutaneously in Multiple Sclerosis) Study Group, & University of British Columbia MS\/MRI Analysis Group. (2001). PRISMS-4: Long-term efficacy of interferon-\u03b2-1a in relapsing MS. Neurology, 56(12), 1628-1636. https:\/\/doi.org\/10.1212\/WNL.56.12.1628","DOI":"10.1212\/WNL.56.12.1628"},{"key":"2012_CR257","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.185.3.01850763","author":"JM Provenzale","year":"2005","unstructured":"Provenzale JM, Mukundan S, Dewhirst M, Provenzale JM (2005) The role of blood-brain barrier permeability in brain tumor imaging and therapeutics. AJR Am J Roentgenol. https:\/\/doi.org\/10.2214\/ajr.185.3.01850763","journal-title":"AJR Am J Roentgenol"},{"issue":"1\u20132","key":"2012_CR258","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jneuroim.2013.04.022","volume":"261","author":"W Qiu","year":"2013","unstructured":"Qiu W, Pham K, James I, Nolan D, Castley A, Christiansen FT et al (2013) The influence of non-HLA gene polymorphisms and interactions on disease risk in a western Australian multiple sclerosis cohort. J Neuroimmunol 261(1\u20132):92\u201397","journal-title":"J Neuroimmunol"},{"key":"2012_CR259","doi-asserted-by":"crossref","unstructured":"Qiu F, Liang CL, Liu H, Zeng YQ, Hou S, Huang S, et al (2017). Oncotarget 268 www.impactjournals.com\/oncotarget Impacts of cigarette smoking on immune responsiveness: Up and down or upside down? [Internet]. Vol. 8, Oncotarget. Available from: www.impactjournals.com\/oncotarget\/","DOI":"10.18632\/oncotarget.13613"},{"issue":"1","key":"2012_CR260","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12974-017-0893-7","volume":"14","author":"M Querol-Vilaseca","year":"2017","unstructured":"Querol-Vilaseca M, Colom-Cadena M, Pegueroles J, San Mart\u00edn-Paniello C, Clarimon J, Belbin O et al (2017) YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer\u2019s disease and other tauopathies. J Neuroinflamm 14(1):118","journal-title":"J Neuroinflamm"},{"key":"2012_CR261","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000369","author":"SV Ramagopalan","year":"2009","unstructured":"Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA et al (2009) Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. https:\/\/doi.org\/10.1371\/journal.pgen.1000369","journal-title":"PLoS Genet"},{"issue":"6","key":"2012_CR262","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/ana.22678","volume":"70","author":"SV Ramagopalan","year":"2011","unstructured":"Ramagopalan SV, Dyment DA, Cader MZ, Morrison KM, Disanto G, Morahan JM et al (2011) Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Ann Neurol 70(6):881\u2013886","journal-title":"Ann Neurol"},{"key":"2012_CR263","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jnr.23886","volume":"95","author":"VS Ratnu","year":"2017","unstructured":"Ratnu VS, Emami MR, Bredy TW (2017) Genetic and epigenetic factors underlying sex differences in the regulation of gene expression in the brain. J Neurosci Res 95:301\u2013310","journal-title":"J Neurosci Res"},{"issue":"9","key":"2012_CR264","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S1474-4422(21)00237-4","volume":"20","author":"DS Reich","year":"2021","unstructured":"Reich DS, Arnold DL, Vermersch P, Bar-Or A, Fox RJ, Matta A et al (2021) Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial. Lancet Neurol 20(9):729\u2013738","journal-title":"Lancet Neurol"},{"key":"2012_CR265","first-page":"30","volume":"18","author":"F Riederer","year":"2017","unstructured":"Riederer F (2017) Ocrelizumab versus placebo in primary progressive multiple sclerosis. J Neurol Neurochirurgie Psychiatrie 18:30\u201331","journal-title":"J Neurol Neurochirurgie Psychiatrie"},{"key":"2012_CR266","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000443","author":"E Rissanen","year":"2018","unstructured":"Rissanen E, Tuisku J, Vahlberg T, Sucksdorff M, Paavilainen T, Parkkola R et al (2018) Microglial activation, white matter tract damage, and disability in MS. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000000443","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2012_CR267","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/jim-2019-001126","volume":"68","author":"JF Rosenthal","year":"2020","unstructured":"Rosenthal JF, Hoffman BM, Tyor WR (2020) CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease. J Invest Med 68:321\u2013330","journal-title":"J Invest Med"},{"issue":"13","key":"2012_CR268","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1212\/WNL.0000000000004411","volume":"89","author":"S Rossi","year":"2017","unstructured":"Rossi S, Studer V, Motta C, Polidoro S, Perugini J, Macchiarulo G et al (2017) Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis. Neurology 89(13):1338\u20131347","journal-title":"Neurology"},{"issue":"4","key":"2012_CR269","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/v15040949","volume":"15","author":"BA Rousseau","year":"2023","unstructured":"Rousseau BA, Bhaduri-McIntosh S (2023) Inflammation and Epstein-Barr virus at the crossroads of multiple sclerosis and post-acute sequelae of COVID-19 infection. Viruses 15(4):949","journal-title":"Viruses"},{"issue":"5","key":"2012_CR270","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1177\/1756285613484079","volume":"6","author":"A Rovira","year":"2013","unstructured":"Rovira A, Auger C, Alonso J (2013) Magnetic resonance monitoring of lesion evolution in multiple sclerosis. Ther Adv Neurol Disord 6(5):298\u2013310","journal-title":"Ther Adv Neurol Disord"},{"key":"2012_CR271","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.3174\/ajnr.A5773","volume":"39","author":"C Saade","year":"2018","unstructured":"Saade C, Bou-Fakhredin R, Yousem DM, Asmar K, Naffaa L, El-Merhi F (2018) Gadolinium and multiple sclerosis: vessels, barriers of the brain, and glymphatics. AJNR Am J Neuroradiol 39:2168\u20132176","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"2012_CR272","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/curroncol31010033","volume":"31","author":"DB Sacdalan","year":"2024","unstructured":"Sacdalan DB, Ul Haq S, Lok BH (2024) Plasma cell-free tumor methylome as a biomarker in solid tumors: biology and applications. Curr Oncol 31(1):482\u2013500","journal-title":"Curr Oncol"},{"key":"2012_CR273","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0404.2009.01221.x","volume":"122","author":"MA Sahraian","year":"2010","unstructured":"Sahraian MA, Radue EW, Haller S, Kappos L (2010) Black holes in multiple sclerosis: definition, evolution, and clinical correlations. Acta Neurol Scand 122:1\u20138","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"2012_CR274","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ana.24487","volume":"78","author":"S Saidha","year":"2015","unstructured":"Saidha S, Al-Louzi O, Ratchford JN, Bhargava P, Oh J, Newsome SD et al (2015) Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study. Ann Neurol 78(5):801\u2013813","journal-title":"Ann Neurol"},{"issue":"3","key":"2012_CR275","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/WCO.0000000000000206","volume":"28","author":"IK Sand","year":"2015","unstructured":"Sand IK (2015) Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr Opin Neurol 28(3):193\u2013205","journal-title":"Curr Opin Neurol"},{"key":"2012_CR276","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"S Sawcer","year":"2011","unstructured":"Sawcer S, Hellenthal G, Pirinen M, Spencer CCA, Patsopoulos NA, Moutsianas L et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214\u2013219","journal-title":"Nature"},{"key":"2012_CR277","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/671730","volume":"2013","author":"E Sbardella","year":"2013","unstructured":"Sbardella E, Tona F, Petsas N, Pantano P (2013) DTI measurements in multiple sclerosis: evaluation of brain damage and clinical implications. Mult Scler Int 2013:1\u201311","journal-title":"Mult Scler Int"},{"key":"2012_CR278","doi-asserted-by":"publisher","first-page":"885218","DOI":"10.3389\/fneur.2022.885218","volume":"13","author":"E Sechi","year":"2022","unstructured":"Sechi E, Cacciaguerra L, Chen JJ, Mariotto S, Fadda G, Dinoto A et al (2022) Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A review of clinical and MRI features, diagnosis, and management. Front Neurol 13:885218","journal-title":"Front Neurol"},{"key":"2012_CR279","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8357","author":"Z Shang","year":"2020","unstructured":"Shang Z, Sun W, Zhang M, Xu L, Jia X, Zhang R et al (2020) Identification of key genes associated with multiple sclerosis based on gene expression data from peripheral blood mononuclear cells. PeerJ. https:\/\/doi.org\/10.7717\/peerj.8357","journal-title":"PeerJ"},{"key":"2012_CR280","doi-asserted-by":"publisher","first-page":"1517369","DOI":"10.3389\/fcell.2025.1517369","volume":"13","author":"K Sheikhi","year":"2025","unstructured":"Sheikhi K, Ghaderi S, Firouzi H, Rahimibarghani S, Shabani E, Afkhami H, Yarahmadi A (2025) Recent advances in mesenchymal stem cell therapy for multiple sclerosis: clinical applications and challenges. Front Cell Dev Biol 13:1517369","journal-title":"Front Cell Dev Biol"},{"key":"2012_CR281","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2147\/JIR.S12059","volume":"3","author":"A Shirani","year":"2010","unstructured":"Shirani A, Tremlett H (2010) The effect of smoking on the symptoms and progression of multiple sclerosis: a review. J Inflamm Res 3:115\u2013126","journal-title":"J Inflamm Res"},{"issue":"2","key":"2012_CR282","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.22043","volume":"68","author":"S Simpson","year":"2010","unstructured":"Simpson S, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H et al (2010) Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 68(2):193\u2013203","journal-title":"Ann Neurol"},{"key":"2012_CR283","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-021-00677-1","author":"A Simpson","year":"2021","unstructured":"Simpson A, Mowry EM, Newsome SD (2021) Early aggressive treatment approaches for multiple sclerosis. Curr Treat Options Neurol. https:\/\/doi.org\/10.1007\/s11940-021-00677-1","journal-title":"Curr Treat Options Neurol"},{"issue":"1","key":"2012_CR284","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40120-017-0086-4","volume":"7","author":"MB Sintzel","year":"2018","unstructured":"Sintzel MB, Rametta M, Reder AT (2018) Vitamin D and multiple sclerosis: a comprehensive review. Neurol Ther 7(1):59\u201385","journal-title":"Neurol Ther"},{"key":"2012_CR285","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179784","author":"C S\u00eerbe","year":"2022","unstructured":"S\u00eerbe C, Rednic S, Grama A, Pop TL (2022) An update on the effects of vitamin D on the immune system and autoimmune diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23179784","journal-title":"Int J Mol Sci"},{"key":"2012_CR286","unstructured":"Smith Begolka Katherine Neville Yael Katz-Levy Laurence M WL, Todd HN, Jeffrey Bluestone Stephen D EA, Vanitih CL, Smii Kothedne Neville WL, Katz-Levy Y, et al 1998. Carol L. Vanderlugt the functional significance of epitope spreading and its regulation by co-stimulatory molecules Author\u2019 addresses."},{"key":"2012_CR287","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s40263-019-00674-8","volume":"33","author":"J Smolders","year":"2019","unstructured":"Smolders J, Torkildsen \u00d8, Camu W, Holm\u00f8y T (2019) An update on vitamin D and disease activity in multiple sclerosis. CNS Drugs 33:1187\u20131199","journal-title":"CNS Drugs"},{"issue":"1","key":"2012_CR288","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","volume":"21","author":"SS Soldan","year":"2023","unstructured":"Soldan SS, Lieberman PM (2023) Epstein-Barr virus and multiple sclerosis. Nat Rev Microbiol 21(1):51\u201364","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"2012_CR289","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.4049\/jimmunol.175.6.4119","volume":"175","author":"KM Spach","year":"2005","unstructured":"Spach KM, Hayes CE (2005) Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 175(6):4119\u20134126","journal-title":"J Immunol"},{"issue":"4","key":"2012_CR290","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1136\/bjophthalmol-2017-310477","volume":"102","author":"RI Spain","year":"2018","unstructured":"Spain RI, Liu L, Zhang X, Jia Y, Tan O, Bourdette D et al (2018) Optical coherence tomography angiography enhances the detection of optic nerve damage in multiple sclerosis. Br J Ophthalmol 102(4):520\u2013524","journal-title":"Br J Ophthalmol"},{"key":"2012_CR291","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/nrneurol.2017.139","volume":"13","author":"M Stangel","year":"2017","unstructured":"Stangel M, Kuhlmann T, Matthews PM, Kilpatrick TJ (2017) Achievements and obstacles of remyelinating therapies in multiple sclerosis. Nat Rev Neurol 13:742\u2013754","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"2012_CR292","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/ana.22320","volume":"69","author":"B Stankoff","year":"2011","unstructured":"Stankoff B, Freeman L, Aigrot MS, Chardain A, Doll\u00e9 F, Williams A et al (2011) Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-11C]-2-(4-methylaminophenyl)- 6-hydroxybenzothiazole. Ann Neurol 69(4):673\u2013680","journal-title":"Ann Neurol"},{"issue":"8","key":"2012_CR293","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1056\/NEJMoa2201904","volume":"387","author":"L Steinman","year":"2022","unstructured":"Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S et al (2022) Ublituximab versus teriflunomide in relapsing multiple sclerosis. N Engl J Med 387(8):704\u2013714","journal-title":"N Engl J Med"},{"key":"2012_CR294","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnagi.2020.00174","volume":"12","author":"JA Stratton","year":"2020","unstructured":"Stratton JA, Eaton S, Rosin NL, Jawad S, Holmes A, Yoon G et al (2020) Macrophages and associated ligands in the aged injured nerve: a defective dynamic that contributes to reduced axonal regrowth. Front Aging Neurosci 12:12","journal-title":"Front Aging Neurosci"},{"key":"2012_CR295","doi-asserted-by":"publisher","DOI":"10.1177\/2055217319894615","author":"KH St\u00fcrner","year":"2019","unstructured":"St\u00fcrner KH, Siembab I, Sch\u00f6n G, Stellmann JP, Heidari N, Fehse B et al (2019) Is multiple sclerosis progression associated with the HLA-DR15 haplotype? Mult Scler. https:\/\/doi.org\/10.1177\/2055217319894615","journal-title":"Mult Scler"},{"issue":"10","key":"2012_CR296","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.2967\/jnumed.116.183020","volume":"58","author":"M Sucksdorff","year":"2017","unstructured":"Sucksdorff M, Rissanen E, Tuisku J, Nuutinen S, Paavilainen T, Rokka J et al (2017) Evaluation of the effect of fingolimod treatment on microglial activation using serial PET imaging in multiple sclerosis. J Nucl Med 58(10):1646\u20131651","journal-title":"J Nucl Med"},{"key":"2012_CR297","doi-asserted-by":"publisher","DOI":"10.1007\/BF03164835","author":"X Sun","year":"1998","unstructured":"Sun X, Tanaka M, Kondo S, Okamoto K, Hirai S (1998) Clinical significance of reduced cerebral metabolism in multiple sclerosis: a combined PET and MR! study. Ann Nucl Med. https:\/\/doi.org\/10.1007\/BF03164835","journal-title":"Ann Nucl Med"},{"issue":"1","key":"2012_CR298","doi-asserted-by":"publisher","first-page":"15183","DOI":"10.1038\/s41598-024-64713-1","volume":"14","author":"C Sun","year":"2024","unstructured":"Sun C, Jia Y, Li H, Qiao X, Tang M, Geng M et al (2024) Healthcare resource utilization and economic burden of multiple sclerosis in Chinese patients: results from a real-world survey. Sci Rep 14(1):15183","journal-title":"Sci Rep"},{"key":"2012_CR299","unstructured":"s0140\u201367362903334\u20130"},{"key":"2012_CR300","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.msard.2016.05.001","volume":"8","author":"S Tavakolpour","year":"2016","unstructured":"Tavakolpour S (2016) Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: a meta-analysis. Mult Scler Relat Disord 8:66\u201373","journal-title":"Mult Scler Relat Disord"},{"issue":"12","key":"2012_CR301","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1093\/brain\/awac307","volume":"145","author":"V Tepav\u010devi\u0107","year":"2022","unstructured":"Tepav\u010devi\u0107 V, Lubetzki C (2022) Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier? Brain 145(12):4178\u20134192","journal-title":"Brain"},{"key":"2012_CR302","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2011.05.009","volume":"11","author":"M Thamilarasan","year":"2012","unstructured":"Thamilarasan M, Koczan D, Hecker M, Paap B, Zettl UK (2012) Micrornas in multiple sclerosis and experimental autoimmune encephalomyelitis. Autoimmun Rev 11:174\u2013179","journal-title":"Autoimmun Rev"},{"key":"2012_CR303","doi-asserted-by":"publisher","unstructured":"Smith, K. J., & Lassmann, H. (2025). The role of nitric oxide in multiple sclerosis. The Lancet Neurology, 1(4), 232-241. https:\/\/doi.org\/10.1016\/S1474-4422(02)00102-3","DOI":"10.1016\/S1474-4422(02)00102-3"},{"issue":"6","key":"2012_CR304","doi-asserted-by":"publisher","first-page":"e1012177","DOI":"10.1371\/journal.ppat.1012177","volume":"20","author":"OG Thomas","year":"2024","unstructured":"Thomas OG, Haigh TA, Croom-Carter D, Leese A, Van Wijck Y, Douglas MR et al (2024) Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis. PLoS Pathog 20(6):e1012177","journal-title":"PLoS Pathog"},{"issue":"3","key":"2012_CR305","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10048-014-0403-3","volume":"15","author":"AL Traboulsee","year":"2014","unstructured":"Traboulsee AL, Bernales CQ, Ross JP, Lee JD, Sadovnick AD, Vilari\u00f1o-G\u00fcell C (2014) Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression. Neurogenetics 15(3):165\u2013169","journal-title":"Neurogenetics"},{"issue":"11","key":"2012_CR306","first-page":"CD012186","volume":"2023","author":"I Tramacere","year":"2023","unstructured":"Tramacere I, Virgili G, Perduca V, Lucenteforte E, Benedetti MD, Capobussi M, Castellini G, Frau S, Gonzalez-Lorenzo M, Featherstone R, Filippini G (2023) Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis. Cochrane Database Syst Rev 2023(11):CD012186","journal-title":"Cochrane Database Syst Rev"},{"key":"2012_CR307","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/354906","author":"C Trompetto","year":"2014","unstructured":"Trompetto C, Marinelli L, Mori L, Pelosin E, Curr\u00e0 A, Molfetta L et al (2014) Pathophysiology of spasticity: implications for neurorehabilitation. BioMed Res Int. https:\/\/doi.org\/10.1155\/2014\/354906","journal-title":"BioMed Res Int"},{"key":"2012_CR308","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.nbd.2009.04.010","volume":"35","author":"H Tumani","year":"2009","unstructured":"Tumani H, Hartung HP, Hemmer B, Teunissen C, Deisenhammer F, Giovannoni G et al (2009) Cerebrospinal fluid biomarkers in multiple sclerosis. Neurobiol Dis 35:117\u2013127","journal-title":"Neurobiol Dis"},{"key":"2012_CR309","doi-asserted-by":"publisher","DOI":"10.1172\/JCI160468","author":"KL Tyler","year":"2022","unstructured":"Tyler KL (2022) The enigmatic links between Epstein-Barr virus infection and multiple sclerosis. J Clin Investig. https:\/\/doi.org\/10.1172\/JCI160468","journal-title":"J Clin Investig"},{"issue":"1","key":"2012_CR310","doi-asserted-by":"publisher","first-page":"7536","DOI":"10.1038\/s41598-022-11444-w","volume":"12","author":"R Umeton","year":"2022","unstructured":"Umeton R, Bellucci G, Bigi R, Romano S, Buscarinu MC, Reni\u00e8 R et al (2022) Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome. Sci Rep 12(1):7536","journal-title":"Sci Rep"},{"issue":"4","key":"2012_CR311","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1370\/afm.983","volume":"7","author":"JM Valderas","year":"2009","unstructured":"Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M (2009) Defining comorbidity: implications for understanding health and health services. Ann Fam Med 7(4):357\u2013363","journal-title":"Ann Fam Med"},{"issue":"7","key":"2012_CR312","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1002\/jmri.26211","volume":"49","author":"EJ van Beek","year":"2019","unstructured":"van Beek EJ, Kuhl C, Anzai Y, Desmond P, Ehman RL, Gong Q et al (2019) Value of MRI in medicine: more than just another test? J Magn Reson Imaging 49(7):e14\u2013e25","journal-title":"J Magn Reson Imaging"},{"key":"2012_CR313","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00760","author":"J van Langelaar","year":"2020","unstructured":"van Langelaar J, Rijvers L, Smolders J, van Luijn MM (2020) B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.00760","journal-title":"Front Immunol"},{"issue":"1","key":"2012_CR314","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4049\/jimmunol.162.1.129","volume":"162","author":"AC van Sechel","year":"1999","unstructured":"van Sechel AC, Bajramovic JJ, van Stipdonk MJB, Persoon-Deen C, Geutskens SB, van Noort JM (1999) EBV-induced expression and HLA-DR-restricted presentation by human B cells of \u03b1B-crystallin, a candidate autoantigen in multiple sclerosis. J Immunol 162(1):129\u2013135","journal-title":"J Immunol"},{"key":"2012_CR315","doi-asserted-by":"publisher","first-page":"1466339","DOI":"10.3389\/fimmu.2024.1466339","volume":"15","author":"A van de Waterweg Berends","year":"2024","unstructured":"van de Waterweg Berends A, Broux B, Machiels B, Gillet L, Hellings N (2024) The EBV-MS connection: the enigma remains. Front Immunol 15:1466339","journal-title":"Front Immunol"},{"issue":"3","key":"2012_CR316","doi-asserted-by":"publisher","first-page":"e1154","DOI":"10.1212\/NXI.0000000000001154","volume":"9","author":"A van den Bosch","year":"2022","unstructured":"van den Bosch A, Fransen N, Mason M, Rozemuller AJ, Teunissen C, Smolders J et al (2022) Neurofilament light chain levels in multiple sclerosis correlate with lesions containing foamy macrophages and with acute axonal damage. Neurol Neuroimmunol Neuroinflamm 9(3):e1154","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"2012_CR317","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1093\/brain\/awv080","volume":"138","author":"MM Van Luijn","year":"2015","unstructured":"Van Luijn MM, Kreft KL, Jongsma ML, Mes SW, Wierenga-Wolf AF, Van Meurs M et al (2015) Multiple sclerosis-associated CLEC16A controls HLA class II expression via late endosome biogenesis. Brain 138(6):1531\u20131547","journal-title":"Brain"},{"key":"2012_CR318","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fneur.2019.00338","volume":"10","author":"KN Varhaug","year":"2019","unstructured":"Varhaug KN, Torkildsen \u00d8, Myhr KM, Vedeler CA (2019) Neurofilament light chain as a biomarker in multiple sclerosis. Front Neurol 10:338","journal-title":"Front Neurol"},{"key":"2012_CR319","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-021-00278-7","author":"M Verma","year":"2022","unstructured":"Verma M, Lizama BN, Chu CT (2022) Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration. Transl Neurodegener. https:\/\/doi.org\/10.1186\/s40035-021-00278-7","journal-title":"Transl Neurodegener"},{"key":"2012_CR320","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2153534","author":"J Verreycken","year":"2022","unstructured":"Verreycken J, Baeten P, Broux B (2022) Regulatory t cell therapy for multiple sclerosis: breaching (blood-brain) barriers. Hum Vaccin Immunother. https:\/\/doi.org\/10.1080\/21645515.2022.2153534","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"2012_CR321","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1111\/ene.14421","volume":"27","author":"A Vidal-Jordana","year":"2020","unstructured":"Vidal-Jordana A, Pareto D, Cabello S, Alberich M, Rio J, Tintore M et al (2020) Optical coherence tomography measures correlate with brain and spinal cord atrophy and multiple sclerosis disease-related disability. Eur J Neurol 27(11):2225\u20132232","journal-title":"Eur J Neurol"},{"key":"2012_CR322","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/124578","volume":"2014","author":"BJ Wade","year":"2014","unstructured":"Wade BJ (2014) Spatial analysis of global prevalence of multiple sclerosis suggests need for an updated prevalence scale. Mult Scler Int 2014:1\u20137","journal-title":"Mult Scler Int"},{"issue":"3","key":"2012_CR323","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/jmri.26942","volume":"52","author":"LL Wald","year":"2020","unstructured":"Wald LL, McDaniel PC, Witzel T, Stockmann JP, Cooley CZ (2020) Low-cost and portable MRI. J Magn Reson Imaging 52(3):686\u2013696","journal-title":"J Magn Reson Imaging"},{"issue":"14","key":"2012_CR324","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA et al (2020) Rising prevalence of multiple sclerosis worldwide: Insights from the atlas of MS third edition. Mult Scler J 26(14):1816\u20131821","journal-title":"Mult Scler J"},{"issue":"1","key":"2012_CR325","doi-asserted-by":"publisher","first-page":"6798","DOI":"10.1038\/s41598-017-07080-4","volume":"7","author":"N Watanabe","year":"2017","unstructured":"Watanabe N, Suzuki Y, Yonezu T, Nakagawa Y, Shiina T, Hirayama N et al (2017) A cell-based high-throughput screening assay system for inhibitor compounds of antigen presentation by HLA class II molecule. Sci Rep 7(1):6798","journal-title":"Sci Rep"},{"issue":"1","key":"2012_CR326","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41598-020-79833-7","volume":"11","author":"M Watanabe","year":"2021","unstructured":"Watanabe M, Nakamura Y, Sato S, Niino M, Fukaura H, Tanaka M et al (2021) HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS\/NMOSD Biobank data. Sci Rep 11(1):607","journal-title":"Sci Rep"},{"key":"2012_CR327","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/acn3.50862","volume":"6","author":"E Waubant","year":"2019","unstructured":"Waubant E, Lucas R, Mowry E, Graves J, Olsson T, Alfredsson L et al (2019) Environmental and genetic risk factors for MS: an integrated review. Ann Clin Transl Neurol 6:1905\u20131922","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"2012_CR328","doi-asserted-by":"publisher","first-page":"15491","DOI":"10.1038\/s41598-021-94891-1","volume":"11","author":"M Weigel","year":"2021","unstructured":"Weigel M, Dechent P, Galbusera R, Bahn E, Nair G, Lu PJ et al (2021) Imaging multiple sclerosis pathology at 160\u00a0\u03bcm isotropic resolution by human whole-brain ex vivo magnetic resonance imaging at 3\u00a0T. Sci Rep 11(1):15491","journal-title":"Sci Rep"},{"issue":"1","key":"2012_CR329","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/08916934.2017.1281914","volume":"50","author":"H Wekerle","year":"2017","unstructured":"Wekerle H (2017) B cells in multiple sclerosis. Autoimmunity 50(1):57\u201360","journal-title":"Autoimmunity"},{"key":"2012_CR330","doi-asserted-by":"publisher","first-page":"101452","DOI":"10.1016\/j.msard.2019.101452","volume":"37","author":"P Wildner","year":"2020","unstructured":"Wildner P, Stasio\u0142ek M, Matysiak M (2020) Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases. Multiple Scler Relat Disord 37:101452","journal-title":"Multiple Scler Relat Disord"},{"key":"2012_CR331","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1172\/JCI41911","volume":"120","author":"EH Wilson","year":"2010","unstructured":"Wilson EH, Weninger W, Hunter CA (2010) Trafficking of immune cells in the central nervous system. J Clin Invest 120:1368\u20131379","journal-title":"J Clin Invest"},{"issue":"1","key":"2012_CR332","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s00401-024-02733-x","volume":"147","author":"F Windener","year":"2024","unstructured":"Windener F, Grewing L, Thomas C, Dorion MF, Otteken M, Kular L et al (2024) Physiological aging and inflammation-induced cellular senescence may contribute to oligodendroglial dysfunction in MS. Acta Neuropathol 147(1):82","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2012_CR333","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1756285611425694","volume":"5","author":"DM Wingerchuk","year":"2012","unstructured":"Wingerchuk DM (2012) Smoking: effects on multiple sclerosis susceptibility and disease progression. Ther Adv Neurol Disord 5(1):13\u201322","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"2012_CR334","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177\u2013189","journal-title":"Neurology"},{"key":"2012_CR335","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T et al (2015b) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189","journal-title":"Neurology"},{"key":"2012_CR336","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/780712","author":"B Wootla","year":"2011","unstructured":"Wootla B, Denic A, Keegan BM, Winters JL, Astapenko D, Warrington AE et al (2011) Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis. Neurol Res Int. https:\/\/doi.org\/10.1155\/2011\/780712","journal-title":"Neurol Res Int"},{"issue":"1","key":"2012_CR337","doi-asserted-by":"publisher","first-page":"9421","DOI":"10.1038\/s41598-025-94303-8","volume":"15","author":"W Yang","year":"2025","unstructured":"Yang W, Liu C, Li Z, Cui M (2025) Multi-omic biomarkers associated with multiple sclerosis: from mendelian randomization to drug prediction. Sci Rep 15(1):9421","journal-title":"Sci Rep"},{"key":"2012_CR338","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.717922","author":"A Yousuf","year":"2021","unstructured":"Yousuf A, Qurashi A (2021) Non-coding RNAs in the pathogenesis of multiple sclerosis. Front Genet. https:\/\/doi.org\/10.3389\/fgene.2021.717922","journal-title":"Front Genet"},{"key":"2012_CR339","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.4103\/1673-5374.237109","volume":"13","author":"Y Yue","year":"2018","unstructured":"Yue Y, Stone S, Lin W (2018) Role of nuclear factor \u03bab in multiple sclerosis and experimental autoimmune encephalomyelitis. Neural Regen Res 13:1507\u20131515","journal-title":"Neural Regen Res"},{"key":"2012_CR340","doi-asserted-by":"publisher","first-page":"1441733","DOI":"10.3389\/fimmu.2024.1441733","volume":"15","author":"A Zabalza","year":"2024","unstructured":"Zabalza A, Pappolla A, Comabella M, Montalban X, Malhotra S (2024) MiRNA-based therapeutic potential in multiple sclerosis. Front Immunol 15:1441733","journal-title":"Front Immunol"},{"issue":"6","key":"2012_CR341","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.neurol.2018.03.006","volume":"174","author":"H Z\u00e9phir","year":"2018","unstructured":"Z\u00e9phir H (2018) Progress in understanding the pathophysiology of multiple sclerosis. Revue Neurol 174(6):358\u2013363","journal-title":"Revue Neurol"},{"issue":"5","key":"2012_CR342","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1212\/WNL.0000000000004885","volume":"90","author":"T Zhang","year":"2018","unstructured":"Zhang T, Tremlett H, Zhu F, Kingwell E, Fisk JD, Bhan V et al (2018) Effects of physical comorbidities on disability progression in multiple sclerosis. Neurology 90(5):e419\u2013e427","journal-title":"Neurology"},{"key":"2012_CR343","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.816098","author":"N Zhang","year":"2022","unstructured":"Zhang N, Zuo Y, Jiang L, Peng Y, Huang X, Zuo L (2022) Epstein-Barr virus and neurological diseases. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2021.816098","journal-title":"Front Mol Biosci"},{"key":"2012_CR344","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076373","author":"X Zhao","year":"2023","unstructured":"Zhao X, Jacob C (2023) Mechanisms of demyelination and remyelination strategies for multiple sclerosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24076373","journal-title":"Int J Mol Sci"},{"key":"2012_CR345","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158160","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Zhang Q, Zhang B, Dai Y, Gao Y, Li C et al (2024) Epstein-Barr viruses: their immune evasion strategies and implications for autoimmune diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25158160","journal-title":"Int J Mol Sci"},{"key":"2012_CR346","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01631-4","author":"X Zheng","year":"2024","unstructured":"Zheng X, Yang J, Hou Y, Shi X, Liu K (2024) Prediction of clinical progression in nervous system diseases: plasma glial fibrillary acidic protein (GFAP). Eur J Med Res. https:\/\/doi.org\/10.1186\/s40001-023-01631-4","journal-title":"Eur J Med Res"},{"key":"2012_CR347","doi-asserted-by":"publisher","first-page":"1221890","DOI":"10.3389\/fcell.2023.1221890","volume":"11","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Zhang J (2023) Neuronal activity and remyelination: new insights into the molecular mechanisms and therapeutic advancements. Front Cell Dev Biol 11:1221890","journal-title":"Front Cell Dev Biol"},{"key":"2012_CR348","doi-asserted-by":"publisher","DOI":"10.2147\/DNND.S73506","author":"H Zimmermann","year":"2014","unstructured":"Zimmermann H, Oberwahrenbrock T, Brandt AU, Paul F, D\u00f6rr JM (2014) Optical coherence tomography for retinal imaging in multiple sclerosis. Degener Neurol Neuromuscul Dis. https:\/\/doi.org\/10.2147\/DNND.S73506","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"2012_CR349","volume-title":"A critical evaluation of vitamin D - clinical overview","author":"SFG Zorzella-Pezavento","year":"2017","unstructured":"Zorzella-Pezavento SFG, Ishikawa LLW, Fraga-Silva TFC, Mimura LAN, Sartori A (2017) Therapeutic and prophylactic potential of vitamin D for multiple sclerosis. A critical evaluation of vitamin D - clinical overview. InTech"},{"key":"2012_CR350","doi-asserted-by":"crossref","unstructured":"Zouali H, Faure-Delanef L, Rard Lucotte G\u00c2 (2025). Chromosome 19 locus apolipoprotein C-II association with multiple sclerosis. DOI: 10.1177\/135245859900500211","DOI":"10.1177\/135245859900500211"},{"issue":"6","key":"2012_CR351","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jgg.2021.03.017","volume":"48","author":"M Zuccal\u00e0","year":"2021","unstructured":"Zuccal\u00e0 M, Barizzone N, Boggio E, Gigliotti L, Sorosina M, Basagni C et al (2021) Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibility. J Genet Genomics 48(6):497\u2013507","journal-title":"J Genet Genomics"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-02012-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-02012-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-02012-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T11:04:13Z","timestamp":1766055853000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-02012-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,8]]},"references-count":351,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2012"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-02012-5","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,8]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable. This article is a narrative review and does not report any studies with human participants, human data\/tissue, animals, or plants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participation"}},{"value":"Not applicable. This article contains no individual person\u2019s data (details, images, or videos).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}